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ABSTRACT
With the advent of high-throughput sequencing technology, modeling molecular 
mechanisms for gene regulatory networks has expanded to include the epigenome. Using 
diverse high-throughput DNA sequencing platforms, previous studies have revealed such 
mechanisms for sex-differential gene regulation in mouse liver. This thesis describes the 
contribution of transcription factor (TF) HNF6 to these models. Further, the utility of 
digital genomic footprinting (DGF) using the DNase-I hypersensitive sites sequencing 
(DNase-Seq) assay or the Assay for Transposase Accessible Chromatin (ATAC-Seq) is 
demonstrated. Finally, this thesis characterizes the extent of post-translational control of 
genes active in mouse liver using the ribosome profiling assay (Ribo-Seq), by way of 
translational efficiency (TE), and uses Ribo-Seq to interrogate open reading frames from 
previously characterized untranslated regions of protein-coding genes and in a set of 
liver-expressed long non-coding RNA genes for evidence of translation. First, mouse 
liver binding sites for HNF6 are integrated for overlap with sex-biased DNase-I 
hypersensitivity sites, male-biased STAT5, and female-specific CUX2 binding sites. This
vi
analysis showed how epigenetic markers, together with HNF6, target specific sets of sex-
biased genes, revealing specific mechanisms involving HNF6 that contribute to the sex-
specificity of gene expression in mouse liver. Next, the limited utility of the DGF 
technique to predict TF-DNA interactions was demonstrated using publicly available 
datasets for 21 TFs using DNase-seq and ATAC-seq datasets and sequencing libraries 
prepared using chromatin as well as purified DNA. Additionally, a simple model is 
proposed that benchmarks performance of DNase-seq vs. ATAC-seq for the same set of 
21 TFs. Finally, the  extent to which liver-expressed genes are regulated by sex-
differential TE was investigated using Ribo-Seq. Limited sex-differential TE was found. 
Further, this assay predicted novel peptides found in previously characterized non-coding
open reading frames within untranslated regions of genes that may regulate TE of 
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CHAPTER 1 – Introduction
1.1 Overview of this dissertation
Sex differences in liver gene expression are primarily regulated by sex differences in 
pituitary growth hormone (GH)  secretion patterns and their differential activation of the 
JAK-STAT signaling pathway in hepatocytes (Waxman & O’Connor 2006). Discovery 
of epigenetic elements that explain sex-differences in gene expression has been facilitated
by recent advances in DNA sequencing technology, which have enabled diverse 
experimental platforms. Specifically, transcription factor (TF) binding sites and DNase-I 
hypersensitivity sites (DHS), i.e., genomic locations enriched for open chromatin, have 
been identified in both male and female mouse liver. Binding sites for several TFs, 
including the liver TF HNF6, have previously been determined by chromatin 
immunoprecipitation with massively parallel DNA sequencing (ChIP-seq) for several 
TFs. Additionally, DNA released by the endonuclease DNase-I (DNase-seq), and more 
recently the transposase Tn5 (ATAC seq), has revealed genome-wide locations for DHS. 
Further, the analysis of nucleotide resolution cut site locations generated by these two 
assays has been proposed as a means to map TF locations genome-wide. While this 
technique, called digital genomic footprinting (DGF), had clear potential for predicting 
TF binding sites, the utility of DGF remains unclear.
Recent advances in RNA sequencing technology include the Ribo-seq platform, which 
has been shown to yield sequence libraries for mRNA that is engaged with the ribosome, 
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to yield genome-wide maps of mRNA undergoing elongation. Using Ribo-seq libraries, 
together with RNA-seq analysis that quantifies transcript abundance within the cell, the 
translational efficiency (TE) of each expressed gene can be determined. TE can provide 
useful information about the post-transcriptional regulation of genes. Ribo-seq also 
provides information about the translation of mRNA sequences annotated as non-coding, 
such as the 5' untranslated regions (uORFs) of genes. Translation of uORFs has been 
proposed as a molecular mechanism that modulates TE of genes.
In this work, I propose an epigenetic model that explains the contribution of the TF 
Hepatocyte Nuclear Factor 6 (HNF6) to sex-differential regulation of genes (Chapter 2). 
Using ChIP-seq datasets for HNF6, I integrated previously described epigenetic models 
to propose a unique contribution of HNF6 to the regulation of sex-specific genes. I 
further explore the utility of the digital genomic footprint (DGF) technique to map 
genome-wide TF binding sites, and illustrate shortcomings of this technique using human
and mouse data from DNase-I-seq and ATAC-seq libraries (Chapter 3). I also interrogate 
male and female livers for sex differences in translational efficiencies, and show how 
cellular localization of transcripts may bias TE values. Finally, I demonstrate how 
translation of uORFs may modulate TE (Chapter 4).
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1.2.1 HNF6 is a liver-expressed transcription factor that regulates sex-specific 
genes together with CUX2
Transfection experiments performed by Dr. Tara Conforto1 as part of a jointly published 
manuscript  (Conforto et al. 2015)  revealed mechanisms by which the transcription 
factor HNF6, together with the transcription factor CUX2 and other previously described 
liver transcription factors (Park & Waxman 2001; Delesque-Touchard et al. 2000), 
regulate sex-specific genes CYP2C11 and CYP2C12. HNF6 and CUX2 have similar 
motifs for DNA binding, and potential the potential for these two factors to compete for 
binding was shown (Conforto et al. 2015).  Further, Dr.  Conforto demonstrated that 
HNF6 repression of CYP2C11 was reversed by HNF1 with CUX2 (Figure 1.1A). 
Additionally, Dr. Conforto found that HNF6 induction of CYP2C12 can be inhibited by 
CUX2, which further demonstrated the potential for regulation of genes by competition 
for binding of HNF6 and CUX2 (Figure 1.1B).
Based on motif analysis and transfection studies showing how HNF6 and CUX2 can 
regulate genes, a ChIP-seq experiment was carried out for HNF6 to determine the 
interaction of HNF6 and CUX2 genome-wide and the specific influence HNF6 may have 
on sex-specific genes. Results from this ChIP-seq experiment were also integrated with 
other data on epigenetic elements, such as TF binding sites for numerous TFs including 
STAT5, and sex-specific DHS. The results of this data integration led to development of 
1 Transfection experiments were carried out by Dr. Tara Conforto within Molecular 
Endocrinology. Confort, Steinhardt and Waxman (2013). “Cross Talk Between GH-
Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver.” as noted in
appropriate places.
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an overall model for the contribution of HNF6 was developed, as described in Chapter 2.
1.3 Limitations of digital genomic footprinting
DNase footprinting was first introduced in 1978 by Galas and Shmitz (Galas & Schmitz 
1978)  as a “simple method for the detection of protein-DNA binding specificity.”  Since 
this discovery, DNA sequencing technology has advanced considerably. This has enabled
a high resolution, genome-wide approach to this technique, first demonstrated for yeast 
cells in 2009 (Hesselberth et al. 2009).  Briefly, TF-DNA interactions interfere with the 
cutting action of DNase-I or the Tn5 transposase, revealing the position of TF  binding 
based on perturbation of signal resulting from TF-DNA interaction. Predicting TF 
binding sites based on cut site information therefore becomes a signal processing 
problem. However, computational methods that attempted to interpret this signal were 
adversely affected by sequence preference of DNase-I for cutting (Lazarovici et al. 
2013) and the corresponding sequence preference of the Tn5 transposase (Madrigal 
2015).  As cuts along the genome are not independent of sequence, for each transcription 
factor binding motif, a similar pattern of cutting was explained by sequence preference of
cutting, and this change in signal was interpreted as a TF-DNA interaction. This artifact 
was clearly demonstrated by He et al. (He et al. 2013).  As the sequence preference of the
Tn5 transposase also hass been described, footprint calling algorithms using signal 
produced from this assay were met with the same issue.
1.3.1 DGF algorithms: benchmarking
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Numerous algorithms have been proposed to identify DNase footprints. Benchmarking of
these tools has become a serious and somewhat contentious issue in the field. In a recent 
review, Gusmao et al. (Gusmao et al. 2016)  benchmarked 10 computational tools 
including one proposed by his own laboratory. The majority of these tools, within their 
respective publications, reported that their tool out-performed others by using area under 
the receiver operating characteristic (AUC of ROC), which plots the true positive rate 
(TPR, sensitivity) against the false positive rate (FPR, specificity). Many publications 
have used this benchmarking technique, and following their lead, this method was used in
my work. According to Gusmao et al., using 100% FPR, which is what is usually 
presented for each tool, there is little difference in performance across all tools 
interrogated for performance. This review goes further by stating that, “using [tag count]-
based strategies/cutoff was significantly better than the original ranking of the methods,” 
strategies simply count reads in the local area of a transcription factor binding motif, 
which reveals the “openness” of the chromatin surrounding the motif. The “original 
ranking of the methods” represented the respective algorithm's scoring metric for putative
binding sites. This chromatin availability  based strategy is comparable to my own “straw
man” approach described in Chapter 3. For any tool, the algorithm must out-perform the 
simple “straw man” approach in order to the use of justify more complicated algorithms. 
From my work and that of Gusmao et al., published tools do not perform as well as was 
originally claimed.
1.3.2 Controversy, DGF, and the state of the art
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Scientists have disagreed on the utility of DGF (Anon 2016).  The March 2016 issue of 
Nature Methods included two papers commenting on the utility of DGF, one skeptical of 
the method (Sung et al. 2016), and one that supported the method (Vierstra & 
Stamatoyannopoulos 2016). In an accompanying editorial the journal did not take a stand 
on the issue, and acknowledged the two contradictory papers, stating that “Disagreements
[can] spur the generation of new evidence and the development of alternative approaches 
that prove or disprove current data interpretation and go beyond present limitations.” 
Despite the publication of more than 10 methods, the lack of standard benchmarking 
techniques for these methods as proposed by the DREAM challenge which has yet to 
produce a publication from results of a 2016 challenge, it has made it difficult to 
determine which analysis technique gives the best results for DGF. Further, the basic 
utility of the technique, independent of the analysis algorithm is still debatable. For these 
reasons, I concluded that implementing this method to analyze our own data is not 
justified (Chapter 3).
1.4 Ribosome profiling: a closer proxy to actual protein levels within a cell than 
RNA-seq
The measurement of mRNA levels within the cell has been used as a proxy for protein 
levels, which ultimately effect cellular functions. According to the central dogma of 
molecular biology, transcription precedes translation, the process of forming a protein. As
such, translation is a later step in this process, and so measuring translation rates and 
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translational efficiency is expected to serve as a closer proxy to protein levels. Transcripts
within the cell have different stabilities, as do different individual proteins 
(Schwanhüusser et al. 2011).  These observations raise questions about the accuracy of 
using mRNA levels to represent protein levels within the cell. The field of proteomics 
struggles with reliable high-throughtput quantification of proteins (Zhang et al. 2014). 
Ribo-seq, an RNA-seq platform that sequences RNAs undergoing the elongation / 
translation step in the process that results in peptide formation, attempts to determine 
more representative protein levels in comparison to mRNA levels.
1.4.1 Translational efficiency of genes as a post-transcriptional regulator
RNA translational efficiency (TE) compares the quantity of ribosome-engaged mRNAs 
against the transcript abundance within the cell, and aims to reveal the degree to which 
translational regulation occurs. TE can be determined from the ratio of abundance of 
sequence reads from the Ribo-seq assay to the transcript abundance, as determined by 
RNA-seq. Several mechanisms for modulation of TE have been identified, including 
regulation by mRNA poly(A) tail length, (Subtelny et al. 2014), and the effect of 
secondary structure within the ribosome binding site (Zydowicz-Machtel et al. 2018).   
Here, in Chapter 4, I have examined sex-differences for TE genome-wide, and 
demonstrate that translation of upstream open reading frames (uORFs) of 5' untranslated 
regions (UTRs) may influence the TE of genes.
1.4.2 Cellular localization and TE
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I also show that cellular localization of genes affects TE. Transcripts within the nucleus 
do not interact with ribosomes, which are found in the cytoplasm, so quantification of 
transcripts from whole-cell lisates do not necessarily represent transcripts that are 
available for translation. Therefore, any TE calculation that uses RNA-seq to measure 
transcripts available for binding to the ribosome is subject to cellular localization bias. In 
a recent review, Ingolia (Ingolia 2016) acknowledged this issue, and described technical 
challenges and limitations in isolating mRNA within specific fractions of the cell. In 
Chapter 4 of this work, I demonstrate that TE values calculated from transcript 
abundances determined by Ribo-seq together with whole liver RNA-seq are indeed 
subject to this bias, and as a consequence, cellular localization needs to be taken into 
consideration when comparing TE values.
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Figure 1.1 Model describing the regulation of CYP2C11 and CYP2C12 by 
competition of binidng for HNF6 and CUX2
HNF6 and CUX2 compete for the same TF binding motif. Relative luciferase reporter 
activity from transient transfection assays shown in (Conforto et al. 2015) showed the 
interaction of HNF6 and CUX2 with other previously described liver expressed TFs. 
Illustrated here is a model based on those experiments.
A) HNF1 together with CUX2 block the inhibiting effect of HNF6 on the sex-specific 
gene CYP2C11. It was postulated that CUX2 cometes for binding by HNF6 resulting in a 
mechanism for regulation of CYP2C11.
B) The inhibitory effect of CUX2 on CYP2C12 was blocked by HNF6 with HNF4 to 
induce the expression of CYP2C12. This shows how competition for binding between 
HNF6 and CUX2 can help explain the reguilation of CYP2C12
9
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CHAPTER 2 – Crosstalk between Growth Hormone-regulated Transcription
Factors HNF6 and CUX2 in Adult Mouse Liver
2.1 Abstract
HNF6 and CUX2 are growth hormone and STAT5-regulated homeobox transcription 
factors. CUX2 shows female-specific expression and contributes to liver sex differences 
by repressing many male-biased genes and inducing many female-biased genes, while 
HNF6 is expressed at similar levels in male and female liver. In cell-based transfection 
studies, CUX2 inhibited HNF6 transcriptional regulation of the sex-specific gene 
promoters CYP2C11 and CYP2C12, blocking HNF6 repression of CYP2C11 and HNF6 
activation of CYP2C12. These inhibitory actions of CUX2 can be explained by 
competition for HNF6 DNA binding, as demonstrated by in vitro EMSA analysis and 
validated in vivo by global analysis of the HNF6 cistrome performed by Dr. Tara 
Conforto. ~40,000 HNF6 binding sites were identified in mouse liver chromatin, 
including several thousand sites showing significant sex differences in HNF6 binding. 
These sex-biased HNF6 binding sites showed strong enrichment for sex-biased DNase 
hypersensitive sites and for proximity to genes showing local sex-biased chromatin marks
and a corresponding sex-biased expression. Further, ~90% of the genome-wide binding 
sites for CUX2 were also bound by HNF6. These HNF6/CUX2 common binding sites 
were enriched for genomic regions more accessible in male than in female mouse liver 
chromatin and showed strongest enrichment for male-biased genes, suggesting HNF6 
displacement by CUX2 as a mechanism to explain the observed CUX2 repression of 
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male-biased genes in female liver. HNF6 binding was sex-independent at a majority of its
binding sites, and HNF6 peaks were frequently associated with co-binding by multiple 
other liver transcription factors, consistent with HNF6 playing a global regulatory role in 
both male and female liver. 
2.2 Introduction
The liver is characterized by widespread sex differences in gene expression (Rinn et al. 
2004; Ahluwalia et al. 2004; Clodfelter et al. 2006; Kwekel et al. 2010; Y. Zhang et al. 
2011) controlled by a complex network of growth hormone (GH)-regulated transcription 
factors, including STAT5, BCL6, CUX2, and several hepatocyte-enriched nuclear factors
(HNFs) (Waxman & Holloway 2009; Meyer et al. 2009; Zhang et al. 2012; Conforto et 
al. 2012; Li et al. 2015).  GH regulates liver STAT5 activity in a sex-dependent manner, 
with STAT5 activated intermittently in males and in a persistent manner in females in 
direct response to the sex-dependent patterns of pituitary GH secretion (Zhang et al. 
2012; Ram 1995).  Stat5b deficiency leads to global loss of sex-biased expression in male
mouse liver, but affects many fewer sex-biased genes in female liver (Clodfelter et al. 
2006).  Liver-specific deletion of HNF4α also leads to a major loss of sex differences in 
the liver, indicating that STAT5b and HNF4α are both required for maintenance of sex 
differences in the liver (Holloway et al. 2008; Holloway et al. 2006). 
STAT5 and HNF4α interact with each other and with a network of other liver-enriched 
transcription factors, including HNF6/Onecut (Nagaki & Moriwaki 2008; Wiwi & 
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Waxman 2004). In primary rat hepatocytes, GH-activated STAT5 and HNF4α both bind 
to and trans-activate the promoter of HNF6, a onecut divergent homeodomain gene 
(Lahuna et al. 2000).  Other studies show, however, that Hnf6 expression is increased in 
livers of male mice deficient in HNF4α, indicating negative regulation of Hnf6 by 
HNF4α (Wiwi et al. 2004).  HNF4α positively regulates the expression of the variant 
homeodomain-containing protein Hnf1α, which negatively regulates Hnf4αα as well as 
itself (Bailly et al. 2001; Hayashi et al. 1999).  HNF6 can trans-activate the genes 
encoding HNF4α and HNF3β (FOXA2), and can negatively regulate HNF3α (FOXA1) 
by inhibition of TGFβ signaling (Plumb-Rudewiez et al. 2004).  Coordinated action 
between HNF6, HNF4α, and the co-activator PGC-1α regulates glucose-6-phosphatase 
during liver development (Beaudry et al. 2006).  Further, STAT5 can enhance HNF4α 
activation of the ApoCIII promoter, while HNF4α can inhibit GH-stimulated STAT5 
activation of the β-caseincasein and Ntcp promoters (Park et al. 2006).  HNF3β is subject to 
positive auto-regulation and, like HNF6, is negatively regulated by HNF4α in male 
mouse liver. HNF3β displays crosstalk with STAT5b and can inhibit STAT5b activation 
of a reporter gene by blocking STAT5b tyrosine phosphorylation (Park & Waxman 
2001). Conversely, STAT5b can inhibit HNF3β activation of the male-specific CYP2C11
promoter as well as the synergistic activation of the female-specific CYP2C12 promoter 
by HNF3β and HNF6 (Park & Waxman 2001; Delesque-Touchard et al. 2000).
 STAT5b regulation of sex-specific gene expression is modulated by cross talk with the 
male-biased repressor BCL6 (Meyer et al. 2009).  which competes with STAT5 for 
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binding at a subset of STAT5 binding sites (Meyer et al. 2009; Park & Waxman 2001; 
Chia & Rotwein 2010) and preferentially binds to female-biased genes in male liver 
(Zhang et al. 2012; Sugathan & Waxman 2013).  Recent studies have identified a 
complementary regulatory network in female liver, involving CUX2 (Gingras et al. 
2005), a highly female-specific repressor that is positively regulated by the more 
continuous plasma GH pattern in female liver, and is negatively regulated by HNF4α and 
STAT5b in male mouse liver (Laz et al. 2007).  CUX2, which belongs to the same 
homeodomain superfamily of transcription factors as HNF6 and HNF1α, binds to, and 
negatively regulates a subset of male-biased genes in female liver (Conforto et al. 2012).  
CUX2 can also positively regulate a subset of female-biased genes, however, in a 
majority of cases this regulation is not associated with direct CUX2 binding and 
apparently proceeds via an indirect mechanism (Conforto et al. 2012). CUX2 binding 
sites identified in female mouse liver are enriched at male-biased DNase hypersensitive 
sites (DHS), i.e. genomic regions where chromatin is more accessible in male liver than 
in female liver (Ling et al. 2010).  CUX2 binding sites also show significant enrichment 
for sites where STAT5 binding is greater in male than female liver (Conforto et al. 2012),
and which are linked to male-biased liver gene expression (Zhang et al. 2012).  Thus, 
CUX2 binding may repress male-specific gene expression in female liver by alteration of 
chromatin accessibility and/or by inhibition of STAT5 activation of male-biased genes. 
CUX2 binding in mouse liver chromatin is described by a motif (Conforto et al. 
2012)  most similar to the motifs for HNF6 (Iyaguchi et al. 2007),  CUX1/CDP (Vadnais 
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et al. 2013).  and another homeodomain protein, PBX1 (Thiaville et al. 2012).  These 
three factors and several other homeodomain-containing proteins are regulated by CUX2,
as indicated by their responsiveness to CUX2 knockdown in female liver and/or CUX2 
overexpression in male liver (Conforto et al. 2012), suggesting a complex interplay 
between CUX2 and other homeodomain transcription factors. In this study, I investigate 
the crosstalk between CUX2 and HNF6 in mouse liver using analysis of the liver HNF6 
cistrome identified by ChIP-seq. Our findings show that a large majority of CUX2 
binding sites in female mouse liver are also binding sites for HNF6, and that CUX2 can 
inhibit HNF6-dependent transcription – both transcriptional activation and transcriptional
inhibition – by a mechanism that involves binding site competition. Unlike CUX2, which
is expressed, and binds exclusively to chromatin, in female mouse liver, HNF6 binding 
was observed in both male and female liver, with distinct subsets of HNF6 binding sites 
occupied in each sex, enabling this liver-enriched transcription factor to contribute both 
to the sex-dependent and the sex-independent expression of many genes, in part by an 
apparently cooperative binding to chromatin in association with multiple other liver-
expressed transcription factors.
2.3 Materials and Methods
2.3.1 High throughput sequencing
HNF6 ChIP-Seq data was obtained from 4 independent young adult male mouse livers 
(biological replicates) and 4 independent young adult female mouse livers (biological 
replicates).  These libraries of ChIP-Seq datasets were prepared by Dr. Tara Conforto as 
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per the methods within (Conforto et al. 2015).  Briefly, DNA isolated by ChIP was 
prepared for 35-40 nt, single-end read sequencing on an Illumina GAII instrument (San 
Diego, CA) carried out at the BioMicro Center at MIT (Cambridge, MA), as described 
(Conforto et al. 2012).  Sequence reads were mapped to the mouse genome (mm9) using 
Bowtie, v0.12.7. Raw and mapped sequence reads are available as GEO series 
GSE60014. Mapped reads from individual male and female livers were combined for 
each sex to give one combined adult male and one combined adult female HNF6 ChIP-
Seq read set. Each read set was analyzed using MACS 2.0 software using default 
parameters (Zhang et al. 2008)  to identify HNF6 peaks (genomic regions showing 
significant HNF6 binding) at MACS -log10(q-value) >25 in male liver, and separately in 
female liver. Liver chromatin immunoprecipitated with rabbit IgG antibody served as a 
negative control for MACS analysis. MAnorm analysis (Shao et al. 2012) was used to 
normalize the HNF6 ChIP-seq data for male and female liver and to identify sets of 
HNF6 peaks that showed a >2-fold enrichment in normalized peak intensity (normalized 
read counts) in male liver compared to female liver, or vice versa (|M| value > 1) after 
merging peaks overlapping between male and female liver samples. This analysis 
resulted in a genome-wide listing of 39,612 HNF6 binding sites, including 4,258 male-
enriched binding sites and 2,428 female-enriched binding sites, as detailed in Table S2 of 
the published work (Conforto et al. 2015).
2.3.2 HNF6 peak set and gene target enrichment analysis.
HNF6 peaks (HNF6 binding sites) were examined for their overlap with the sets of 
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72,862 liver DHS and their sex-biased subsets (Ling et al. 2010), 15,094 liver STAT5 
binding sites and their sex-biased subsets (Zhang et al. 2012), and 1,471 female liver 
CUX2 binding sites (Conforto et al. 2012).  Enrichment scores (ES) for the overlap were 
calculated in comparison to those of background sets comprised of all HNF6 peaks not in
the HNF6 peak set being examined. Significance was assessed by two-tail Fisher's exact 
test, with ES > 1.5 combined with p-value < 0.002 deemed significant. Gene targets of 
HNF6 binding sites were defined as all genes whose gene body extends to within 10 kb 
of an HNF6 ChIP-seq peak. Where indicated, HNF6 peaks were mapped to genes using 
GREAT (McLean et al. 2010)  based on the basal plus extension association rule, 
extending 10 kb upstream of genes, 2 kb downstream, and up to 50 kb distally. Gene 
targets of sets of male-enriched, female-enriched, and sex-independent HNF6 binding 
sites identified by MAnorm were examined for enrichment for clusters of gene ontology 
(GO) and other annotation terms using DAVID (Huang et al. 2009).  DAVID analysis of 
targets of sex-independent HNF6 peaks was carried out using 3,000 gene targets of sex-
independent HNF6 peaks having the lowest MACS 2.0 q-value (i.e., the strongest HNF6 
peaks). Enrichment for HNF6 target genes that show sex-biased expression, as 
determined by RNA-seq (Sugathan & Waxman 2013),  were calculated for all liver-
expressed male and female biased genes, and for 6 subsets of male-biased genes (M1 to 
M6) and 6 subsets of female-biased genes (F1 to F6) classified by their proximal sex-
specific chromatin mark patterns, as defined earlier (Sugathan & Waxman 2013)  and 
specified in Table S2 of the published work from (Conforto et al. 2015). Significance was
assessed by two-tail Fisher's exact test in comparison to a background set of gene targets 
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of sex-independent + sex-opposite HNF6 binding sites. 
2.3.3 Motif discovery
De novo motif discovery using CisGenome (Ji et al. 2008)  was performed using HNF6 
peak summit regions (a 51 bp window centered on the MACS 2.0 peak summit), with the 
full sets of sex-enriched HNF6 peaks and the top ~3,500 sex-independent HNF6 peaks 
(lowest MACS 2.0 q-values) analyzed separately. Motifs were also discovered for the 
subsets of HNF6 peaks that overlap, or do not overlap, CUX2 binding sites (Conforto et 
al. 2012).  STAMP, a UPGMA (Unweighted Pair Group Method with Arithmetic Mean) 
distance-based-method (Mahony & Benos 2007),  was used to quantify information 
content differences between motifs. Motif enrichment in the HNF6 peak summit regions 
(+/- 200 bp of peak summit at FDR < 1E-4) was determined using CENTDIST (Z. Zhang
et al. 2011) for the full set of vertebrate motifs from the TRANSFAC database (Matys 
2006)  supplemented by a set of 97 motif families defined previously (Macisaac et al. 
2006)  and by the sets of de novo discovered motifs describing HNF6 binding sites 
identified as described above. Summit regions for the full sets of male- and female-
enriched HNF6 peaks, the set of 3,000 top sex-independent HNF6 peaks that do not 
overlap a CUX2 binding site, and the set of 1,228 sex-independent HNF6/CUX2 
common peaks were each analyzed by CENTDIST separately. For the sex-independent 
HNF6 peak sets, the summit of the stronger peak in male or female liver was used for the 
analysis. CENTDIST results were analyzed to identify the set of top scoring motifs (score
>12) that occur in > 10% of the peak summit regions (+/- 200 bp) in at least one of the 
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HNF6 peak sets examined, based on a motif scan performed by CENTDIST, after 
eliminating duplicate or redundant motifs (UPGMA < 0.001). 
2.3.4 Co-binding with other liver transcription factors
Peak summit regions of the 39,612 HNF6 peaks were analyzed for proximity to ChIP-seq
binding sites identified in adult male mouse liver for six other liver-expressed 
transcription factors: HNF1A (ArrayExpress E-MTAB-941), HNF3B/FOXA2 (GEO 
series GSE32244), HNF4A (GEO series GSE22078), CEBPB (GEO series GSE42321), 
STAT5 (GEO series GSE31578) and GR/NR3C1 (GEO series GSE45674). Sequence 
reads from these studies were used to call binding sites using MACS in analyses reported 
previously (Zhang et al. 2012)  or carried out by Gracia Bonilla and Dr. Tisha Melia of 
this laboratory. Peak lists are provided in Table S3 within the published work (Conforto 
et al. 2015). A liver factor was defined as being co-bound with HNF6 if its ChIP-seq peak
center was within 200 nt of the HNF6 peak summit identified by MACS2. For each 
HNF6 peak set examined (including the subsets of HNF6 peaks whose peak summits 
overlapped with, or that did not overlap with a DHS region), we calculated the expected 
distribution of the number of liver transcription factor co-binding events. Thus, for each 
of the 6 factors, the percentage p of HNF6 peaks co-bound represents a probability of 
factor co-binding with HNF6, and 1-caseinp represents the probability that a factor is not co-
bound with HNF6. Using these probabilities, expected co-binding frequencies were 
calculated for each of 7 bins, representing 0 to 6 co-binding events (i.e., ranging from 
only HNF6 bound to HNF6 co-bound with all 6 factors). For example, there are 15 
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possible combinations of 4 co-bound factors in the set of 6 factors. For each of these 15 
combinations, probabilities p and 1-p for bound and unbound are assigned for each of the 
6 factors. The product of these 6 probabilities represents the probability of observing 4 
co-factors bound for a given transcription factor combination. The sum of these 15 
products, one for each possible combination, represents the total probability of having 4 
factors co-bound. The expected and the observed co-binding frequencies were then 
compared using a chi-squared test, and p<1.0E-6 was used to identify distributions 
significantly different from the expected. HNF6 peaks were considered to contain an 
HNF6 motif, or a cohesin-non-CTCF site (CNC site) (Quaggin et al. 1996), if such a 
motif (or CNC site) was found within 200 nt of the HNF6 peak summit. 
2.4 Results
2.4.1 Characterization of the liver HNF6 cistrome 
I used ChIP-seq to characterize mouse liver HNF6 binding sites genome-wide and 
establish the global extent of CUX2 and HNF6 binding site competition. A total of 
39,612 peaks of HNF6 binding were identified in male and female mouse liver (Table S2,
(Conforto et al. 2015)).  Of these peaks, 43.7% overlapped with the set of 72,862 mouse 
liver DNase I hypersensitive sites (DHS) (merged DHS set (Ling et al. 2010)), which 
correspond to open chromatin regions and are highly enriched in gene regulatory regions.
The percentage of HNF6 binding sites that overlap with a DHS increased to ~75% when 
the top 10,000 HNF6 binding sites (ranked by MACS score) were considered (Fig. 2.1). 
In contrast, the overlap with DHS is > 90% for other liver-enriched transcription factors, 
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with the exception of CEBPA (67%) and the pioneer factor FOXA2 (68%) (Zhang et al. 
2012; Ling et al. 2010).
Quantitative comparison of the male and female liver HNF6 ChIP-seq datasets 
normalized using MAnorm (Shao et al. 2012)  identified 4,258 HNF6 peaks showing 
significantly higher binding activity in male liver and 2,428 HNF6 peaks showing 
significantly higher binding activity in female liver (Table S2 within(Conforto et al. 
2015)).  These sex-enriched HNF6 binding sites showed strong enrichment for the 
corresponding sets of sex-specific DHS: male-enriched HNF6 peaks were highly 
enriched (6.6-fold) for being at a male-specific DHS (p=3.41E-198), and correspondingly
for female-enriched HNF6 peaks being at a female-specific DHS (ES = 10.48, p=2.11E-
64) when compared to background sets of HNF6 peaks not in the HNF6 test peak set 
(Table 2.1). Further, when considering the subsets of sex-enriched HNF6 peaks 
overlapping liver DHS (809 male-enriched HNF6 peaks (19% of total set) and 755 
female-enriched HNF6 peaks (31% of total set), the enrichments increased to 45-fold 
(male-enriched HNF6 peaks; p=0), and 16.8-fold (female-enriched HNF6 peaks; p=8.8E-
80) (Table 2.1). Thus, there is a strong association between sex-dependent HNF6 binding 
and the sex-dependence of chromatin accessibility. Comparison to the set of 15,094 
mouse liver binding sites for STAT5 identified previously (Zhang et al. 2012)  showed 
that the full set of male-enriched HNF6 peaks was significantly associated with male-
enriched STAT5 binding sites (ES=4.12, p=2.37E-84) and correspondingly for female-
enriched HNF6 peaks and female-enriched STAT5 binding sites (ES 3.45, p=4.87E-20) 
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(Table 2.1). These enrichments increased to 11.3-fold (p=4.03E-128) and 5.08-fold 
(p=3.41E-26) when the subsets of sex-specific HNF6 sites at DHS were considered. Fig. 
2.2 and Fig. 2.3 show examples of female-enriched and male-enriched HNF6 binding 
sites (marked in pink and blue, respectively), along with nearby sex-biased genes, DHS, 
and binding sites for other GH-regulated transcription factors.
2.4.2 Relationship of HNF6 binding to CUX2 binding sites
More than 90% of the 1,471 CUX2 binding sites identified in female mouse liver 
(Conforto et al. 2012) overlap with a peak of HNF6 binding (Table S2 within (Conforto 
et al. 2015)), consistent with the close similarity of HNF6 and CUX2 motifs (Fig. 2.4) 
and supporting the proposal that CUX2 competes with HNF6 for binding to these sites in 
female liver. De novo motif discovery using summit regions of the strongest HNF6 peaks
that do not overlap a CUX2 peak yielded a motif very similar to the Transfac HNF6 motif
(motif 4A, Fig. 2.4) and to the CUX2 motif identified previously (motif 2) (Conforto et 
al. 2012).  A subset of sequences in the HNF6 peak set yielded a second, related motif 
containing a 5’ extension of several adenines (motif 4B, Fig. 2.4). The male-enriched and
female-enriched HNF6 peak summit regions yielded de novo discovered motifs that were 
indistinguishable from each other (UPGMA distance <0.001) and from the top HNF6 
motif (motifs 5 and 6 vs. motif 4A; Fig. 2.4). Thus, sequence differences at the HNF6 
binding site do not determine the sex-differences in HNF6 binding. Further, HNF6/CUX2
common peaks and HNF6 peaks not bound by CUX2 yielded indistinguishable motifs 
(motif 7 vs. motif 4A), indicating that sequence differences at the binding site do not 
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explain DNA binding preferences in mouse liver chromatin for HNF6/CUX2 common 
binding site vs. HNF6 binding alone. 
HNF6/CUX2 common binding sites showed significant enrichment for overlap with 
male-biased DHS (ES 4.28, p=3.22E-16) and for genomic regions that show male-
enriched STAT5 binding (ES 5.96, p=4.45E-67) as compared to HNF6 peaks not 
overlapping CUX2 binding sites (Table 2.1). Based on these findings, and given that 
CUX2 binding occurs exclusively in female liver, owing to the absence of CUX2 protein 
in male liver (Laz et al. 2007),  we anticipated that the set of HNF6/CUX2 common sites 
found at DHS would show a significant preference for male-enriched HNF6 binding 
when compared to the set of HNF6 peaks at DHS that are not bound by CUX2; however, 
no such enrichment was seen (ES=1.17, p=0.27).  However, we did find that the set of 
HNF6/CUX2 common peaks at DHS was significantly depleted of female-enriched 
HNF6 peaks at DHS (ES=0.31, p=4.33E-08), consistent with CUX2 being preferentially 
bound at these sites in female liver as compared to HNF6. Thus, while CUX2 binding is 
not enriched at sites of male-enriched HNF6 binding, CUX2 binding is significantly 
depleted at female-enriched HNF6 binding sites. 
2.4.3 HNF6-associated factor motifs
Transcription factor co-motifs associated with HNF6 binding sites were identified using 
CENTDIST (Z. Zhang et al. 2011).  The set of 3,000 strongest sex-independent HNF6 
peaks (lowest MACS q-values) that do not overlap with a CUX2 peak was analyzed, as 
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was each sex-enriched HNF6 peak set, to discover any differences in co-motifs between 
peak sets (Table 2.2). As expected, the highest scoring motifs described HNF6 itself and 
several transcription factors with similar binding site specificities (i.e. CUX2, 
CUX1/CLOX and PBX). In addition, several co-motifs were commonly associated with, 
and were found in close proximity to, the HNF6 peak summits at frequencies ranging up 
to ~20%. The highest scoring co-motifs described the liver-enriched transcription factors/
factor families HNF4, HNF1, HNF3/FOX and C/EBP, which variously interact with each
other and with STAT5 to regulate sex-dependent liver gene expression (Wiwi & Waxman
2004).  Other HNF6 co-motifs with lower scores include those describing members of the
CDX, POU, and SRY transcription factor families. Overall, results were similar for all 
three HNF6 peak sets. No significant differences in co-motifs were seen for HNF6/CUX2
common peak set as compared to the sex-independent HNF6 peak set (Table 2.2), 
indicating that CUX2 binding is not driven a differential association with co-motifs 
compared to the HNF6-only peak set.
To test the above prediction that HNF6 binding is significantly associated with binding 
by other liver transcription factors, we examined published male mouse liver ChIP-seq 
binding data for six transcription factors. Factors whose binding sites are within 200 bp 
of an HNF6 peak summit were considered as co-bound with HNF6. Each of the six 
factors (HNF1A, HNF3B/FOXA2, HNF4, CEBPB, STAT5 and GR/NR3C1) showed 
substantial co-binding with the set of 3,000 top-scoring HNF6 binding sites (Fig. 2.5A). 
Many more co-binding events were seen at the 2,381 HNF6 sites within DHS compared 
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to the 619 HNF6 sites not in DHS regions, consistent with the strong preference of these 
and other transcription factors for binding to open chromatin (Ling et al. 2010).  Factor 
co-binding frequency distributions (values ranging from 0 to 6 other factors co-bound 
with HNF6) were significantly different than the expected distributions, both for HNF6 
binding sites at DHS (Fig. 2.5B) and for HNF6 binding sites not at DHS (Fig. 2.5C). 
Specifically, HNF6 binding sites at DHS showed >2-fold enrichment for: (a) co-binding 
with all 6 other factors; and (b) co-binding with no other factors (singleton binding event)
or co-binding with only one other factor (Fig. 2.5B). Similarly, HNF6 sites not at DHS 
showed >2-fold enrichment for co-binding with 4, 5 or 6 other factors, and for no other 
factors being co-bound (Fig. 2.5C). A similar overall pattern of enrichment for multi-
factor co-binding was seen for the subset of male-specific HNF6 sites within DHS, but 
with an even greater enrichment for singleton HNF6 sites (Fig. 2.6A).
Many (39%) of the top 3,000 HNF6 binding sites either do not contain an HNF6 motif, or
contain a motif below the detection threshold of our motif scan analysis, suggesting 
HNF6 binds to these sites, at least in part via interactions with other directly bound 
transcription factors. We did not, however, see a striking differential distribution of factor
co-binding events at HNF6 binding sites with vs. without an HNF6 motif (Fig. 2.6B). We
also examined the association between factor co-binding events and presence of a 
cohesin-non-CTCF site (CNC site), which is involved in chromosome looping and can 
stabilize cis-regulatory modules occupied by multiple tissue-specific regulators, including
HNF6 (Quaggin et al. 1996).  This stabilization is reported to enable HNF6 and other 
25
liver transcription factors to bind chromatin even in the absence of a strong cognate motif
(Quaggin et al. 1996)  did not show a preference for HNF6 sites without (or with low-
scoring) HNF6 motifs: c.f. HNF6 motif frequency of 61.7% in the set of 1,453 CNC site-
overlapping top HNF6 peaks vs. 61% in all top 3,000 HNF6 peaks. When considering all 
39,612 HNF6 peaks, the corresponding motif frequencies were 53.7% for all HNF6 peaks
vs. 45.7% for the subset of CNC-overlapping HNF6 peaks. Further, the reported positive 
impact of the presence of a CNC site on the recruitment of multiple co-factors was not 
apparent in our analysis: the presence of a CNC site had no obvious impact on the 
distribution of co-factor binding events at HNF6 sites localized to DHS (Fig. 2.6C).
2.4.4 HNF6 target genes and pathways - Analysis of gene targets of HNF6 peaks, 
defined as genes within 10 kb of an HNF6 binding site, identified gene targets for 68% of
the binding sites (Table S2 within (Conforto et al. 2015)).  The set of 3,000 genes 
targeted by the top sex-independent HNF6 peaks was significantly associated with 
diverse biological functions, including cytochrome P450/microsomal drug metabolism, 
nucleotide binding, steroid metabolic process, zinc finger/steroid hormone receptors, 
metal ion binding, lipid transport, negative regulation of transcription, pleckstrin 
homology and GTPase regulation (Table S4A within (Conforto et al. 2015)). Gene targets
of female-enriched but not male-enriched HNF6 peaks were also significantly associated 
in cytochrome P450/microsomal drug metabolism, nucleotide binding, metal ion binding 
and zinc finger/steroid hormone receptors, but were additionally associated with positive 
regulation of transcription, ubiquitin conjugation and chromatin organization (Table S4B 
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within (Conforto et al. 2015)).  Significant associations of gene targets of male-enriched 
HNF6 peaks were different from the sex-independent and female-enriched HNF6 target 
gene groups. These associations included small GTPase binding, metal ion binding, 
calcium-dependent membrane targeting, phospholipase C, synapse and cytoskeletal 
protein binding, in addition to pleckstrin homology and metal ion binding, which were 
shared with the other two gene sets (Table S4C within (Conforto et al. 2015)). Thus, 
male-enriched and female-enriched HNF6 binding targets genes are associated with 
distinct cellular and metabolic functions.
The association of sex-biased HNF6 binding sites with nearby (within 10 kb) sex-biased 
genes was examined by enrichment analysis. Female-biased HNF6 binding sites showed 
3.05-fold enrichment for mapping to one or more female-biased genes (p=1.75E-39) and 
2-fold depletion for mapping to male-biased genes (p=8.48E-08) as compared to non-
female-enriched HNF6 binding sites. In contrast, male-biased HNF6 binding sites did not
show enrichment for mapping to male-biased genes (ES=1.07, p=4.1E-01), but were 
3.57-fold depleted for mapping to a female-biased gene (ES= 0.28; p=1.21E-25) as 
compared to non-female-enriched HNF6 binding sites (Table 2.3). When we examined 
the enrichment of sex-biased HNF6 binding sites at individual subclasses of sex-biased 
genes grouped based on their sex-dependent local chromatin states (Sugathan & Waxman
2013),  I observed an even more striking enrichment of female-enriched HNF6 sites 
mapping to genes in female gene subclass F2 (ES=4.46, p=1.35E-14) as well as subclass 
F3 (ES=17.2, p=2.55E-27) (Table 2.3 and Fig. 2.2), which has the highest frequency of 
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nearby, sex-biased chromatin marks (Sugathan & Waxman 2013).  Further, male-
enriched HNF6 sites now showed significant enrichment for a corresponding subclass of 
male-biased genes with proximal male-biased chromatin marks (subclass M3; ES=2.86, 
p=1.5E-03). The enrichment for male subclass M3 increased to ES=5.83, p=2.13E-04 
when only the male-enriched HNF6 binding sites within DHS regions were considered. 
Even more striking enrichments of male-enriched HNF6 binding sites for the male-biased
M3 gene subclass were observed when HNF6 binding sites were mapped to genes using 
GREAT’s basal plus extension association rule (McLean et al. 2010):  ES=4.76, 
p=3.42E-06 when all male-enriched HNF6 binding sites were considered, and ES=14.35, 
p=2.61E-09 when male-enriched HNF6 binding sites mapping to DHS were considered. 
These findings were confirmed when we considered the number of sex-biased gene 
targets of sex-enriched HNF6 binding sites. Thus, female subclass F3 genes were 6.26-
fold enriched for being targets of female-enriched HNF6 binding sites as compared to a 
background set of gene targets of non-female-enriched HNF6 binding sites, and male 
subclass M3 genes were 3.76-fold enriched for being targets of male-enriched HNF6 
binding sites as compared to the gene targets of non-male-enriched HNF6 binding sites 
(Table S5 within (Conforto et al. 2015)).
Examination of gene targets of HNF6/CUX2 common peaks revealed their significant 
enrichment for both male-specific and female-specific genes, with stronger enrichments 
of the HNF6/CUX2 common peaks in gene subclasses F3 (ES=4.05, p=7.63E-04) and 
M4 (ES=4.85, p=1.11E-07) (Table 2.3), both of which have local, sex-biased chromatin 
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marks (Sugathan & Waxman 2013).  Very similar results were obtained when the 
enrichments were calculated based on the number of gene targets (rather than the number 
of peaks mapping to gene targets) in each gene class. Thus, gene targets of HNF6/CUX2 
common peaks were most highly enriched in sex-biased gene subclasses F1 (ES=1.95, 
p=9.55E-15), F3 (ES=6.45, p=7.07E-05), M1 (ES=2.4, p=3.33E-06), and M4 (ES=8.99, 
p=9.74E-07) (Table S5 within (Conforto et al. 2015)),  consistent with the finding that 
CUX2 both represses male-biased genes and induces female-biased genes (Conforto et al.
2012).
2.5 Discussion
The regulation of sex-biased gene expression in mouse liver involves the action of GH 
via multiple, interacting transcription factors, including STAT5 and BCL6, whose 
overlapping binding sites enable BCL6 to preferentially repress a subset of GH and 
STAT5-regulated female-biased genes in male mouse liver (Zhang et al. 2012).  A 
complementary mechanism has been identified in female liver, whereby CUX2, a highly 
female-specific transcription factor, represses a substantial subset of male-biased genes. 
This repression is associated with CUX2 binding to chromatin at sites that are associated 
with male-enriched binding of STAT5 and are more accessible in male than in female 
liver (Conforto et al. 2012).  Here, we investigate the crosstalk of CUX2 with HNF6, a 
homeobox-containing protein with a DNA-binding specificity similar to CUX2.
The binding site motif identified for CUX2 (Conforto et al. 2012)  is most similar to the 
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motifs describing binding sites used by HNF6, CUX1/CDP (Fig. 2.4), and another 
homeodomain protein, PBX1. EMSA analysis carried out by Tara Conforto (Conforto et 
al. 2015)  confirmed that CUX2 and HNF6 (as well as CUX1 and the related factor OC-
2) bind similar DNA sequences; however, each factor also displayed unique DNA-
binding site specificity. From this work, even small differences in sequence of the DNA 
binding site may lead to diverse outcomes, as HNF6 can bind DNA either with or without
its homeodomain and CUX2 can bind DNA through various combinations of its three Cut
regions and the homeodomain (Gingras et al. 2005; Iyaguchi et al. 2007).  Isoforms of 
HNF6 that differ in their DNA binding specificities are also known (Lannoy et al. 1998). 
HNF6 interacts with the co-activator p/CAF when bound to the TTR promoter, which 
involves HNF6’s homeodomain and Cut domain, while HNF6 interacts with the co-
activator CBP when bound to the HNF3β/FOXA2β/FOXA2FOXA2 promoter, which involves only the 
HNF6 Cut domain (Iyaguchi et al. 2007).  The recognition sequences for these two DNA 
binding activities of HNF6 differ by only one base pair (Iyaguchi et al. 2007).  HNF6-
stimulated transcription may also be modulated by interactions with co-activators, as 
indicated by the increased stability of HNF6 protein, and by its ability to stimulate Glut2 
promoter activity, when acetylated by CBP (Rausa et al. 2004).  Although specific DNA 
sequences that discriminate between HNF6 and CUX2 DNA binding in vitro could be 
found in work done by Tara Conforto (Conforto et al. 2015),  de novo motif discovery did
not reveal motif differences between HNF6 binding sites that do vs. do not overlap with 
binding sites for CUX2 in mouse liver in vivo (motif 4A vs. motif 7, Fig. 2.4). Thus, liver
binding specificities for HNF6 binding vs. HNF6/CUX2 common binding cannot be 
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explained by the underlying DNA motifs. 
The close similarity between HNF6 and CUX2 DNA binding site motifs, and their ability
to bind common sequences in both EMSA and global ChIP-seq analyses, indicate that 
these two factors bind to common sites, and provide strong support for the proposal that 
the observed inhibitory action of CUX2 on HNF6 transcriptional activity involves 
binding site competition. Indeed, 91% of the CUX2 peaks identified in female mouse 
liver (Conforto et al. 2012)  overlapped with an HNF6 peak identified by ChIP-Seq. The 
total number of HNF6/CUX2 common binding sites is likely greater than the 1,338 sites 
identified here, given that the number of liver CUX2 binding sites identified previously 
(1,471 sites) is limited by the low titer of the available CUX2-specific antibody, as 
discussed (Conforto et al. 2012).  CUX2 binding to chromatin is seen in female but not 
male liver, where CUX2 expression is nearly undetectable at the protein and RNA levels 
(Laz et al. 2007);  consequently, binding site competition between CUX2 and HNF6 is 
restricted to female liver (Fig. 2.7). While we thus anticipated that the set of 
HNF6/CUX2 common peaks would preferentially show a male-enriched pattern of HNF6
binding, this was not seen. The set of HNF6/CUX2 common peaks was, however, 
significantly depleted of female-enriched HNF6 binding sites, supporting the conclusion 
that CUX2 binding to the HNF6/CUX2 common sites in female liver competes out HNF6
binding, which decreases the likelihood of female-enriched HNF6 binding at such sites. 
We also found that HNF6/CUX2 common sites are significantly enriched for chromatin 
regions more open in male than in female liver (male-biased DHS (Ling et al. 2010)), 
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which helps explain the depletion of female-enriched HNF6 binding at these sites (Fig. 
2.7). 
HNF6 is an important global activator of hepatic gene expression (Wang & Holterman 
2012),  and the displacement of HNF6 by CUX2 at a subset of HNF6 binding sites 
indicated by our findings could be a mechanism by which CUX2 directly selectively 
represses gene expression, in particular, male-biased gene expression in female liver 
(Conforto et al. 2012), where CUX2 is specifically expressed (Laz et al. 2007).  My 
finding that HNF6/CUX2 common binding sites are enriched at male-biased DHS, and 
also at male-enriched STAT5 binding sites, both of which are strongly associated with 
male-biased gene expression (Zhang et al. 2012; Ling et al. 2010),  suggests that CUX2 
binding counters positive interactions of HNF6 with GH pulse-activated STAT5 in 
regulating male-biased gene expression. HNF6 but not CUX1 is likely to be involved in 
this cooperative, positive regulation of male-biased genes, as CUX1 protein levels are 
strongly down regulated in mouse liver beginning at E18.5, and is nearly extinguished 
when male-biased gene expression emerges at adulthood by the action of liver 
microRNA-122, via its binding site in the 3’-UTR of CUX1 mRNA (Xu et al. 2010).  
Supporting this model, HNF6/CUX2 common binding sites showed significant 
enrichment for proximity to male-biased genes, with the strongest enrichment seen at 
gene targets belonging to male-biased gene subclass M4 (Table 2.3, Table S5 within 
(Conforto et al. 2015)),  which is one of two male gene subclasses showing enrichment 
for proximal male-biased chromatin marks (Sugathan & Waxman 2013).  However, we 
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also observed significant enrichment of HNF6/CUX2 common binding sites at female-
biased genes, most notably members of female gene subclass F3, which is characterized 
by local chromatin marks and includes several highly female-biased genes whose 
expression is apparently regulated by CUX2 via a direct binding mechanism (Conforto et 
al. 2012), such as Cyp2b9 and Cyp3β/FOXA2a4α4α (Fig. 2.2; Fig. 2.7).
HNF6 binding to liver chromatin occurred at a similar level in male and female mice at 
the vast majority (> 90%) of HNF6 binding sites, however, sex-biased HNF6 binding was
seen at a few thousand sites. Female-enriched HNF6 binding sites and their target genes 
were significantly enriched in several classes of female-biased gene targets, most notably 
genes comprising female subclass F3 (Fig. 2.2), which has the highest frequency of local 
female-enriched activating chromatin marks and local male-enriched repressive 
chromatin marks (Sugathan & Waxman 2013).  Male-enriched HNF6 binding sites were 
correspondingly enriched at male subclass M3 gene targets, which are characterized by 
proximal male-biased chromatin marks (Sugathan & Waxman 2013) (Fig. 2.7).  These 
significant associations with sex-biased genes having proximal sex-biased chromatin 
marks raise the possibility that the occurrence of such chromatin marks may be a better 
predictor of HNF6 peak-gene target interactions than linear proximity alone. The sets of 
male-enriched and female-enriched HNF6 binding sites also showed strong enrichment 
for localization at open chromatin regions (DHS) showing the same sex-bias. Thus, the 
sex-dependence of HNF6 binding is strongly associated with, and may be directly 
determined by the sex-dependence of chromatin accessibility, as was also seen for the 
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sex- and plasma GH pattern-dependent binding of STAT5 to mouse liver chromatin 
(Zhang et al. 2012).  Nevertheless, and in contrast to liver STAT5 binding sites, a 
substantial fraction of the sex-enriched HNF6 binding sites identified here were not 
associated with sex-specific DHS, and could not be attributed to differences in HNF6 
motif between male-biased and female-biased binding sites. Further studies are required 
to fully understand the factors and mechanisms that determine sex differences in HNF6 
binding and the potential role of sex-differential chromatin states in the establishment and
maintenance of these sex differences in factor binding.
HNF6 regulation of target genes can be modulated by crosstalk with other transcription 
factors, including co-factors recruited to nearby genomic sequences. Motif analysis of 
HNF6 peak regions showed high scores for motifs associated with HNF1, HNF4α, 
HNF3/FOX and C/EBP family members (Table 2.2), consistent with earlier reports that 
these liver-enriched transcription factors work in a combinatorial manner to regulate 
hepatic gene expression (Odom 2004; Kyrmizi et al. 2006), including sex-dependent gene
expression (Wiwi & Waxman 2004). Comparison to published male mouse liver ChIP-
seq datasets for these four liver transcription factors, as well as datasets for STAT5 and 
GR, revealed a significantly greater than expected frequency of multiple co-binding 
events than expected by chance, suggesting cooperativity in liver factor binding, in 
particular for HNF6 sites found in DHS regions (Fig. 2.5). At the same time, HNF6-only 
binding events (singleton binding), primarily in non-DHS genomic regions, were also 
more frequent than expected. HNF6 and HNF3β/FOXA2 can synergistically activate the 
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female-specific CYP2C12 promoter, with HNF6 potentially acting as a co-activator and 
recruiting p300/CBP proteins (Park & Waxman 2001; Rausa et al. 2003).  HNF6 has also
been shown to synergize with HNF1α and C/EBPα, and with HNF4α (Yoshida et al. 
2006),  consistent with the motif co-associations seen here. Other HNF6 co-factor motifs 
identified here include members of the CDX, POU and SRY families. Cooperation 
between HNF6 and CDX in regulating postnatal intestinal development has been reported
(Maier et al. 2006), and hepatoblasts stimulated by GH can differentiate into biliary 
epithelial cells (cholangiocytes) that co-express HNF6 and the SRY family factor SOX9 
(Dianat et al. 2014). Further studies are required to elucidate the interactions of HNF6 
with these co-factors and to define roles they might play in modulating HNF6-dependent 
regulatory events linked to sex-specific gene expression in the liver.
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Figure 2.1  Impact of HNF6 peak MACS 2.0 q-value cutoff on overlap with DHS.
Overlap of HNF6 peaks with DHS in male and female mouse liver. HNF6 peaks are 
sorted by -log10(q-value) and placed into 20 bins along the X-axis.  The percentage of 
HNF6 peaks in each bin that overlap with the full set of 72,862 mouse liver DHS (Ling et
al. 2010) is plotted along the Y-axis. A small but steady increase in % overlap with DHS 
with increasing HNF6 peak quality is seen until bin 14 (marked in red). For peaks from 
male and female liver, MACS 2.0 q-values < 1.0E-25 is satisfied for bins 14-20. Accord-
ingly, a cutoff q-value of 1.0E-25 was established. Approximately 50% of these HNF6 
peaks overlap with DHS for male and female liver. The percent overlap increases to 
~75% when only the top 10,000 peaks from male and female liver are considered.
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Figure 2.2 Female-enriched HNF6 binding sites associated with subclass F3 female-
biased genes.  Shown are examples of subclass F3 genes (Sugathan & Waxman 
2013)  along with browser tracks indicating the locations of DHS, and binding sites for 
STAT5, BCL6, CUX2 and HNF6. Sex-independent DHS and transcription factor binding
sites are colored grey, female-enriched sites are colored pink, and sites of BCL6 binding 
in male liver are colored blue. Binding sites for STAT5 and BCL6 are shown as a 600 nt-
wide window surrounding the ChIP-seq peak summit. For the DHS track, a greater inten-
sity of pink color indicates a larger sex-difference in chromatin accessibility. Also shown 
are normalized wig files of HNF6 ChIP-seq reads for male and female liver. A, the 
Sult3β/FOXA2a1 + Rsph4α1 genomic region is associated with 5 female-enriched and 1 sex-inde-
pendent HNF6 site; only 3 of these six HNF6 sites coincide with a DHS. B, Cyp2b9 is as-
sociated with 11 nearby female-enriched and 1 sex-independent HNF6 site, with none 
found at a DHS. C, Cyp3β/FOXA2a4α4α is associated with 2 female-enriched and 2 sex-independent 
HNF6 sites, of which 2 are located at DHS regions. One of the female-enriched HNF6 
sites downstream of Cyp2b9 and one of the sex-independent HNF6 sites upstream of 
Cyp3β/FOXA2a4α4α overlaps a CUX2 binding site. Data for DHS (Ling et al. 2010), and binding 
sites for CUX2 (Conforto et al. 2012), STAT5 and BCL6 (Laz et al. 2007) determined by
ChIP-seq are based on prior publications.
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Figure 2.3 Male-enriched HNF6 binding sites associated with male-biased genes 
Shown are examples of male-biased genes along with browser tracks indicating the loca-
tions of DHS and binding sites for the indicated transcription factors, and wig files for 
HNF6 ChIP-seq reads for male and female liver, as in Fig. 5. Blue indicates male-en-
riched DHS and male-enriched binding sites for the indicated factors. A, the C6 genomic 
region is associated with 7 male-enriched HNF6 sites, 5 of which overlap a DHS. B, 
Cyp4αa12a is associated with 3 male-enriched HNF6 sites and 1 sex-independent HNF6 
site, with 2 of these 4 sites found at a DHS. C, Hsd3β/FOXA2b5 is associated with 4 male-enriched
and 5 sex-independent HNF6 sites, 6 of which are located at or close to DHS regions. Lo-





Figure 2.4 Motifs for HNF6 and CUX2 DNA binding motifs are represented by se-
quence logos, and are based on the Transfac database (motifs numbered 1, 3A, 3B) or 
were determined by de novo discovery using the indicated subsets of the present HNF6 
ChIP-seq data sets (motifs 4-7) or the published CUX2 data set (motif 2) (Conforto et al. 
2012). Motifs 4A and 4B were discovered using the top ~3,500 HNF6 peaks that do not 
overlap with a CUX2 binding site; the major motif, 4A, is based on 1,450 HNF6 binding 
sites, and the minor motif, 4B, is based on 401 sequences present within the full list of 
~3,500 HNF6 peaks. Motifs similar to 4B were discovered de novo in the analyses that 
yielded motifs 5, 6 and 7 (not shown). Motifs 5, 6, and 7 are respectively based on 1,089, 
561 and 466 HNF6 binding site-containing sequences.
41
   
       
42
Figure 2.5 Co-binding frequency distributions for the top-scoring 3,000 HNF6 peak 
summit regions. 
A, Heat maps of transcription factor co-binding events for 2,381 HNF6 peaks at DHS 
(top) and for 619 HNF6 peaks not at DHS (bottom). Each black bar indicates a co-bind-
ing event for the transcription factor marked at bottom. In each heat map, HNF6 peaks 
are ordered by the number of factors co-bound, ranging from 6 factors (top) to zero fac-
tors (bottom). B, Distribution of number of co-binding events for the sets of HNF6 peak 
summit regions at DHS, with red bars representing the observed frequencies of 0-6 co-
binding events, and grey bars representing the expected distribution based on the percent-
age overlaps with individual co-factors (see Methods). C, Distribution of number of co-
binding events for the sets of HNF6 peak summit regions not at DHS, with blue bars rep-
resenting the observed frequencies of 0-6 co-binding events, and grey bars representing 
the expected distribution based on the percentage overlaps with individual co-factors de-
termined experimentally (see Methods).
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Figure 2.6 Distributions of the number of observed transcription factor co-binding 
events for the indicated sets of HNF6 peak summit regions, ranging from 0 to 6.   
(A) subsets of male-specific HNF6 peaks in DHS (red) or not in DHS (blue), (B) subsets 
of the top-scoring 3,000 HNF6 peak summit regions with an HNF6 motif (red) or an 
HNF6 motif (red), and (C) subsets of the top-scoring 3,000 HNF6 peak summit regions 
that are within a DHS region and also contain a CNC site (red) or are within a DHS re-
gion and do not contain a CNC site (blue). Each panel also shows at the left the number 
of HNF6 peaks in each subset of peaks. Grey bars represent the expected without distri-




Figure 2.7  Model for regulation of sex-biased genes by HNF6 in adult male and fe-
male mouse liver. Regulation of male-caseinbiased genes (left): HNF6 binds to male-enriched 
binding sites within male-biased DHS regions nearby male-biased genes, in particular 
class M3 genes (Table 2.3), leading to transactivation. This transactivation is often asso-
ciated with male-biased STAT5 binding (Fig. 2.3). CUX2 is exclusively expressed in fe-
male liver, where it competes with HNF6 for binding at a subset of HNF6 binding sites 
based on their common sequence motifs (Fig. 2.4), leading to loss of HNF6-dependent 
transactivation and repression of male-biased gene expression, in particular class M4 
genes (Table 2.3). Regulation of female-caseinbiased genes (right): Female-biased HNF6 bind-
ing occurs within female-biased DHS regions nearby female-biased gene classes F1, F2, 
and F3 leading to transactivation. CUX2 binding is seen at a subset of these female-bi-
ased HNF6 binding sites (in particular, nearby M3 genes; Fig. 2.2 and Table 2.3), and is 
associated with female-biased gene activation. This activating effect of CUX2 on a subset
of female-biased genes contrasts with the suppressive effects of CUX2 on male-biased 
genes (Li et al. 2015).  A subset of the sex-enriched HNF6 binding sites identified were 
not associated with sex-biased DHS (not illustrated). Transfection studies (Fig. 1 within 
(Conforto et al. 2015)) show that CUX2 can also modulate sex-biased gene transcription 
by counteracting transcriptional inhibitory effects of HNF6 (not illustrated)
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Table 2.1. Enrichment of HNF6 peak sets for overlap with DHS and with sex-en-
riched binding sites for STAT5 and CUX2 in mouse liver
Shown are enrichment scores (ES) and p-values for overlap between the sets of male-en-
riched, female-enriched, or CUX2-overlapping HNF6 peaks, and the indicated sets of 
DHS, STAT5 binding sites, and CUX2 binding sites. ES for overlap with male and fe-
male-biased DHS were calculated for the full sets of male-enriched and female-enriched 
HNF6 peaks, and for the subsets comprised of 809 male-enriched HNF6 peaks and 755 
female-enriched HNF6 peaks that are at DHS (ES and p-values in lower row, shown in 
italics). The ES values shown indicate the bias of a given HNF6 peak set for overlap with
the indicated set of DHS, or the indicated set of transcription factor binding sites, com-
pared to a background set comprised of all HNF6 peaks not in the HNF6 peak set being 
examined. For example, male-enriched HNF6 binding sites are 6.59-fold enriched for 
overlapping male-biased DHS compared to HNF6 peaks that are not male-enriched, with 
the enrichment increasing to 45-fold when the set of 809 male-enriched HNF6 binding 
sites at DHS is considered. Significant enrichments are highlighted in bold. ES values < 1
at a p-value < 0.002 indicate significant depletion. The numbers of HNF6 peaks in each 
peak set are shown at the top, and the numbers of DHS, STAT5 and CUX2 sites are 
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0.10 3.82E-17 3.45 4.87E-20 0.77 3.82E-08
Male-enriched 
STAT5 sites (1,765)
4.12 2.37E-84 0.17 2.63E-17 5.96 4.45E-67
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Table 2.2. Top-scoring motifs in sets of sex-independent, male-enriched and female-
enriched HNF6 peak summits determined by CENTDIST analysis   Shown are the 
motif center distribution scores, which are based on the frequency and velocity graphs of 
motif distribution (sum of CENTDIST Z0 and Z1 scores (Z. Zhang et al. 2011), respec-
tively), and percent values, which indicate the percent of HNF6 peak summit regions 
having one or more motif occurrences within a +/- 200 bp window at FDR < 1E-04. Data 
are shown for all motifs with center distribution score >12 and >10% motif occurrence 
for at least one of the four HNF6 peak sets shown here. Closely related motifs (UPGMA 
<0.001), such as CUX2, which is redundant with the de novo HNF6 motif (see Fig. 2B), 
are not listed. The motif V$CLOX_01 is representative of CUX1. The higher motif distri-
bution scores and occurrence frequencies in the set of top 3,000 sex-independent HNF6 
peak set not overlapping with CUX2 binding sites compared to the two sex-enriched 
HNF6 peak sets is a reflection of the weaker mean HNF6 binding (lower MACS 2.0 q-
values) of the latter peak sets. Similarly, the higher motif scores and occurrence frequen-
cies of the male-enriched compared to the female-enriched HNF6 peak sets may reflect 
the weaker HNF6 peak intensities of the female-enriched peak set. 
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Table 2.3. Enrichment of HNF6 peak sets for sets of sex-biased gene targets
The enrichment scores and associated p-values shown represent the bias for the members 
of each sex-enriched HNF6 peak set to map to sex-biased gene targets in gene subclass 
F1-F6 and M1-M6 compared to a background set of HNF6 peaks not in the sex-enriched 
HNF6 peak set. For example, female-enriched HNF6 peaks map to subclass F3 gene tar-
gets at a 17.2-fold greater frequency than male-enriched + sex-independent HNF6 peaks. 
Corresponding male-enriched HNF6 peaks are depleted of the indicated classes of fe-
male-biased gene targets (ES < 1 at p < 0.002). The ES for male-enriched HNF6 peaks 
mapping to male-biased gene set M3 increases from 2.86 to 4.76 when the HNF6 peaks 
are mapped to genes using the basal plus extension peak-gene association rule of GREAT
(see Methods). Significant enrichments are highlighted in bold. Gene subclasses not 
showing enrichments at p<0.002 for at least one of the three HNF6 peak sets are not 
shown. NS, not significant (p>0.002). 
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*, 12 of the 17 male-enriched HNF6 binding sites mapping to the M3 subset of male-
biased genes by GREAT analysis are in DHS regions (ES=14.35, p=2.61E-09, as 
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compared to non-male enriched HNF6 binding sites in DHS regions mapping to M3 
genes). At 9 of the 17 HNF6 binding sites mapping to M3 genes, HNF6 is bound in the 
presence of either zero (7 HNF6 sites) or one (2 HNF6 sites) of the 6 other liver 
transcription factors that often co-bind with HNF6 (c.f. Fig. 7), with a significant 
enrichment for M3 genes (ES=4.85, p=7.97E-04, as compared to non-male enriched 
HNF6 binding sites co-boun with either 0 or 1 other liver factors).
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CHAPTER 3 Limitations of Digital Genomic Footprinting
3.1 Abstract
DNase-seq is a technique that releases fragments of DNA from regions of open 
chromatin.  Many studies have proposed models to predict transcription factor-DNA in-
teractions using the signal generated from DNase cut sites that release DNA fragments 
(Boyle et al. 2011; Hesselberth et al. 2009). This technique has become an object of con-
troversy, due to sequence bias of DNase-I, as well as the limitations of algorithms tasked 
with footprint calling (He et al. 2012; Gusmao et al. 2016). Recently, ATAC-seq, which 
yields signal from fragments released by Tn5 transposase, has been proposed as an alter-
native method for detecting open chromatin regions (Buenrostro et al. 2013).  Here, I 
show that, using publicly available human cell line data,  Tn5 transposase and DNase-I 
both show strong sequence bias of cutting hexamers, which ranges ~300-fold in compari-
son to a background of hexamers within the genome.  In addition, using footprint calls 
generated from the msCentipede algorithm (Raj et al. 2015) there was little difference in 
performance of the two assays, and overall the performance of each assay was TF depen-
dent.  Using data from our lab and from the ENCODE project, msCentipede analysis of 
DNase-I signal from male mouse liver yielded performance that was matched by a sim-
pler model.  Calling footprints using scores generated by msCentipede did not outperform
a model in which footprints were called based on on DNase-I accessibility alone.  Data 
from this laboratory was interrogated according to guidelines from a recent reviewon 
DNAs-seq footprinting (Vierstra & Stamatoyannopoulos 2016), which included a recom-
mended fragment length of < 125 bp and a signal to noise ratio of 50% reads in peaks for 
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footprint signal optimization.  For these data and following this recommendation, I found 
that, despite partitioning reads by size selection in silico, shorter reads achieve only 
~30% of sequence reads in open chromatin peaks compared to ~25% of longer reads.  I 
therefore concluded that it was ill advised to prepare additional libraries with short DNA 
fragments.  For the purpose of investigating male mouse liver using external and internal 
DNase-seq data, the utility of digital genomic footprinting was found to be extremely 
limited.
3.2 Introduction
Molecular mechanisms for gene regulation include transcription factor binding 
events in which transcription factors (TFs) bind to DNA and regulate gene expression.  
Transcription factor binding sites (TFBS) along with their gene targets are essential for 
constructing epigenetic models of gene regulation. Binding sites for a given transcription 
factor are most often mapped using high throughput sequencing technology, such as 
chromatin immunoprecipitation with massively parallel sequencing (ChIP-seq).  This 
technique yields a set of sequence reads enriched at binding sites for a particular TF.
Recently, methods for predicting TFBS for all TFs genome-wide using DNase-seq have 
been proposed (Pique-Regi et al. 2011; Raj et al. 2015).  These methods leverage the 
signal generated from DNase cleavage of open chromatin to predict TF-DNA 
interactions.  According to previous studies, where TFs are bound to DNA, perturbation 
of the DNase-seq signal should be observed because  TF binding interferes with the 
cutting action of DNase-I (Vierstra & Stamatoyannopoulos 2016).  Based on this 
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principle, signal analysis of DNase-I cut sites within the genomic region surrounding a 
transcription factor motif can be used to call a motif as bound or unbound.   However, 
these studies have been met with much criticism.  In some cases, binding site predictions 
are explained not by TF-DNA interaction, but by the sequence bias of DNase-I  (He et al.
2013; Sung et al. 2016).  DNase sequence bias has been described previously (Lazarovici 
et al. 2013). Sequence enrichment of DNase-I cutting sites was shown to encompass a 
hexamer spanning the cut site.  From this work, DNase-I has been shown to have a well-
defined sequence preference.  This sequence dependence of DNase-I cleavage may 
adversely affect footprinting algorithms.
A recently introduced method for discovery of open chromatin sites called ATAC-seq 
uses the Tn5 transposase to release fragments for sequencing (Adey et al. 2010; Davie et 
al. 2015).  This simple assay may provide a suitable alternative to the use of DNase-I for 
mapping open chromatin.  The signal generated by cuts at these sequenced fragments 
were found to be enriched at DNase hypersensitivity sites (DHS) that define open chro-
matin.  It is postulated that for digital genomic footprinting, this method may yield foot-
prints comparable or better than those called with DNase-Seq.  The sequence recognition 
site for Tn5 has also been described, suggesting that the transposase will show bias in 
cutting as observed for DNase-I (Madrigal 2015).
Here, we show that DNase-I and Tn5 released fragments both have issues of sequence 
bias within their respective recognition sites.  For the hexamer site that encompasses 3 nts
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up and downstream from the cut, we quantify and compare the sequence bias of DNase-I 
and ATAC cleavage.  To illustrate the effect of sequence bias on signal generated from 
DNase-seq to that of ATAC-seq experiments, I used sequence read sets from both 
chromatin and purified genomic DNA. The potential for sequence bias to confound 
footprint calling algorithms is revealed in plots of cumulative cut sites for genomic 
locations anchored at transcription factor motifs.  The overall performance for calling 
footprints using fragments released by DNase-I and Tn5 is calculated and compared.  
Motif sets for which ChIP-seq data is available are interrogated for presence of footprints,
and these called footprints are compared to a set of corresponding “gold standard” or 
known binding sites generated from the corresponding ChIP-seq studies.
Next, the practical utility of footprint calling using DNase-seq libraries for male mouse 
liver was examined. I used DNase-seq libraries prepared in this lab and ChIP-seq-
determined binding sites generated by this lab and by others.  Additionally, previous 
efforts for other algorithms are shown to consistently out-perform simpler models for 
predicting TF binding.  For these simpler models, motifs are called as bound within open 
chromatin regions, and no consideration is made for per nucleotide resolution cutting 
Any footprint calling algorithm must significantly out-perform this simpler “straw man” 
model to justify more complex computation. Here, I analyzed DNase-seq read sets with 
msCentipede (Raj et al. 2015), and used ChIP-seq binding sites to benchmark 
msCentipede and a “straw man” model 
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Guidelines for generating high quality DNase reads are laid out in a recent review 
(Vierstra & Stamatoyannopoulos 2016).  These guidelines suggest selecting DNA 
fragments of shorter length (length < 125 nts) prior to sequencing, recommend a high 
signal to noise ratio for reliable detection of footprints.  Here, I used our dataset of 
paired-end DNAse-seq reads to partition DNA fragments by size in silico.  From these 
partitioned read sets, signal to noise was calculated and compared across small and large 
DNA fragments, and single genomic locations were qualitatively interrogated for 
evidence of footprints.  From these findings, the overal utility of genomic footprinting for
these data was established.
3.3 Materials and Methods
3.3.1 Sequence bias of DNase-I and Tn5 the Tn5 transposase.
Previous investigations of both DNase-I (Lazarovici et al. 2013) and Tn5 (Madrigal 
2015) reveal enrichment of certain sequences spanning the cut site.  For DNase-I, 
Lazarovici et al demonstrate sequence enrichment for 3nts up and downstream from a cut
site (a hexamer spanning the cut site).  The bias of DNase-I cutting at this hexamer 
sequence recognition site was quantified.  Additionally, Madrigal has shown sequence 
enrichment surrounding cuts made by Tn5 that are within, but not limited to, the same 
hexamer observed for DNase-I (Supplementary Figure 1).  The bias of cutting for 
hexamers observed for DNase-I and Tn5 was quantified as the fold change of observed 
hexamers spanning cut sites vs the expected number of hexamers modeled from a 
background of hexamer counts within the genome.  For both DNase-I and Tn5, sequence 
reads for purified genomic DNA from human cell lines (He et al. 2013; Grøntved et al. 
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2012) were used to count hexamers spanning cut sites.  For the 4,096 possible nucleotide 
hexamers, the number of observed hexamers mapped using fragments released by 
DNase-I and Tn5 was counted.  This count, normalized by the number of reads, vs. the 
number of hexamers found within the genome represented the fold change enrichment of 
observed hexamers vs expected:
FCenrichment= log2(( OBSERVEDkmercountEXPECTEDkmercount )∗(
4096 kmersgenomewide
totalreadcount ))
For each of the possible 4,096 hexamers, this fold change was calculated.  Fold change 
enrichments for all hexamers were sorted and plotted separately for DNase-I and Tn5, re-
vealing the possible range of cutting bias for DNase-I and Tn5 separately (Figure 1).
3.3.2  DNase-I and the Tn5 transposase sequence bias: cumulative profiles of motifs
The human genome was scanned for a set of transcription factor binding motifs 
corresponding to 31 publicly available ChIP-seq experiments for human cell line 
GM12878.  Genome-wide locations for the 31 motifs and the corresponding ChIP-Seq 
determined binding site locations flagged each motif as bound or unbound, yielding  
bound and unbound motif sets for each of the 31 TFs.  For the set of unbound motifs, 
these motifs were downsampled to 10,000 in order to closely match the number of motifs 
determined as bound (bound motif sets ranged from ~30,000 to a few hundred).  
Cumulative profile plots of cuts within the genomic region spanning 100 nts up and 
downstream from the motif were made for bound and unbound motif sets.  This was done
using signal from sequence fragments released by DNase-I and Tn5.  Additionally, plots 
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using signal from purified genomic DNA digested by both DNase-I and Tn5 for unbound 
motif sets were generated, yielding a set of 6 plots for each motif (Supplementary figure 
S3.2).  For DNase-I, chromatin from cell lines GM12878 (GSE29692) and purified 
genomic DNA from cell line IMR90 (GSE18927) were used.  Corresponding reads 
generated using the ATAC method for both chromatin (GM12878 GSM1155961) and 
purified genomic reads (NA18507 Sequence read archive project : SRP004087) were also
analyzed.  
3.3.3  PIQ performance: DNase-I and ATAC assays
Sequence reads from DNase-seq and ATAC-seq experiments were used to compare these
techniques' utility for digital genomic footprinting (DGF) using the footprint calling algo-
rithm PIQ (Sherwood et al. 2014).  Using reads from DNase-seq and ATAC-Seq experi-
ments, with ChIP-seq peaks called by the ENCODE project as a gold standard, I bench-
marked PIQ for calling footprints.  Reads from open chromatin assays and ChIP-seq-de-
termined binding sites were from the GM12878 human cell line (ENCODE project, see 
Materials and Methods section 3.3.6).  First, PIQ performed a scan of the human genome 
for a set of 31 TFs for which ChIP-Seq data is available using the pwmmatch.r mod-
ule.  This scan of motifs produced a set of called motifs for a given TF.  Each motif was 
interrogated by the PIQ algorithm using signal generated by each of the open chromatin 
assays separately.  Individual samples were given to the algorithm using the bam2rda-
ta.r module for both assays, with .bam files for each individual assay as input.  PIQ la-
bels each motif as bound or unbound. Motifs called as footprints were classified as within
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or not within a previously determined “gold standard” binding site.  From this, the per-
centage of footprints called at gold standard binding sites represented the performance of 
PIQ for calling true footprints at real binding sites.  The performance of PIQ for each TF 
motif was summarized in a bar chart with the percentage of footrpints within “gold stan-
dard” binding sites plotted for each assay.
3.3.4  Benchmarking msCentipede: Waxman laboratory data
DNase-seq libraries for male mouse livers were prepared and sequenced in this lab by Dr.
Connerney.  Each sample was digested with DNase-I and the libraries were generated and
sequenced.  For each individual, sequence reads from the DNase-Seq assay were pro-
cessed through an internal Waxman lab pipeline.  This pipeline performed two main qual-
ity control steps: a fastq quality control using the Fastx toolkit, and confirmation that 
each sequence read had the same read length.  The reads were then mapped to the mouse 
genome using Bowtie2 (Langmead & Salzberg 2012) with parameters specified in the 
pipeline.  From these mapped reads, DNase-I cut sites were mapped to the leftmost end 
of the read for positive-stranded reads, and the rightmost end for negative-stranded reads.
Signal generated from mapped cut sites for individual male livers were used in down-
stream analysis.  msCentipede was used to call footprints using the following input data 
sets. DHS regions were scanned for 7 TF binding motifs: CEBPA, CEBPB, CTCF, 
FOAA2, HNF1A, HNF4A. and RXR.  A scan of all DHS in mouse liver (Ling et al. 
2010) using the FIMO module of the MEME suite of motif tools (Grant et al. 
2011) yielded sets of genomic locations for these motifs.  From these motif locations, a 
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region spanning 50 nts up and downstream from the motif start were interrogated for sig-
nal generated from mapped cut sites.  Specifically, for each motif, all nt positions within 
the specified region were interrogated for signal generated from DNase-I cuts where the 
signal is the number of cuts.  This was done for all nts in the specified genomic region 
surrounding the motif, for all motifs.  Each genomic location spanning a motif therefore 
had signal generated by DNase-I cutting.  Next, the msCentipede algorithm was used to 
take the DNase-I signal and call motifs as bound or unbound based on the signal sur-
rounding the motif that is explained by TF-DNA interaction.  The signal spanning each 
motif in a set was parsed into the appropriate format as per the tool guidelines and foot-
prints were called using default parameters, using the default msCentipede model.  For 
each motif, a footprint score was calculated by msCentipede, representing the probability 
of a binding event.  In addition, each set of motifs had corresponding ChIP-Seq-deter-
mined TF binding sites.  Using the footprint score and bound / unbound status of each 
motif, the performance of msCentipede was benchmarked using the area under the re-
ceive-operator curve (ROC).  Briefly, motifs were ranked by the footprint score generated
by msCentipede.  For a given motif within this ranked set, all higher ranked motifs were 
flagged as having a footprint, and all motifs with lower rank were flagged with not hav-
ing a footprint.  Using the ChIP-Seq experiments as a “gold standard,” the set of ranked 
motifs were either correctly or incorrectly flagged as bound / unbound.  This was done 
for each motif in the ranked set.  From this information, the sensitivity (true positive rate, 
TPR) and specificity (false positive rate, FPR) were calculated for each motif.  The TPR 
and FPR then plotted as an ROC curve.  Additionally, this benchmarking of msCentipede
64
was compared to a much simpler model.  This “straw man” model used chromatin avail-
ability as a ranking metric in place of the footprint score.  Here, all motif regions were 
ranked by the number of DNase-seq reads within the region.  That is, all motif regions in 
a set of motifs interrogated for footprints were ranked by DNas-seq read count.  TPR and 
FPR and subsequent AUC values were calculated using both ranking metrics (Supple-
mentary Figure 3).
3.3.5  Fragment length analysis
Recent work presents guidelines for optimizing DNase-seq libraries for footprinting 
(Vierstra & Stamatoyannopoulos 2016).  According to these guidelines, short reads (<125
bps) yield DNase-I signal capable of showing true footprints.  Paired-end reads from 
male mouse liver DNase-seq datasets(G82, G115) were partitioned by DNA fragment 
size.  Each read set was mapped using bowtie2 using an internal lab pipeline.  This 
pipeline yielded a set of .bam files of mapped reads, with a size distribution plot for each 
sample (Supplementary Figure S3.4).  All samples were combined into one paired-
end .bam formatted read set.  This read set was converted to bedpe format via bamToBed 
with the -bedpe option, which gave the start and end for each released DNA fragment.  
Reads were subsequently partitioned by size for 4 sets outlined below:
B1:  all reads from DNA fragment length < 125bp
B2:  Largest reads where the number of reads equals that of set B1
B3β/FOXA2:  shortest 1/FOXA23β/FOXA2rd of all reads
B4α:  longest 1/FOXA23β/FOXA2rd of all reads
Read set B1 satisfies the guidelines from Veristra and Stamatoynnopoulos.  B2 contrasts 
this set in that the same number of reads are included, however reads are of the maximum
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possible length given our read set, and therefore should have significantly lower 
performance, eg percentage of reads in peaks.  Comparing B1 and B2 therefore shows the
effect that the recommended read length may have on the percentage of reads in peaks.  
B3 and B4 sets represent the shortest 1/3rd of all reads and the longest 1/3rd respectively,
and are compared as B1 and B2 to reveal the effect that read length has on the percentage
of reads in peaks.  Additionally, cut sites for each read were mapped and visualized on 
the UCSC genome browser, where the left side of the DNA fragment is red, and the right 
side blue.  For each released DNA fragment in the paired-end library, each cut site was 
mapped as a single nucleotide where the mapped site was one nt directly upstream from 
the cut.  In Figure a schematic diagram of the BEDPE-formatted where 'o' represents the 
start of the read, and 'x' represents nucleotides within the read as per the .bed file format.
Here, the BEDPE-formatted file represents the released fragment start and end.  The left 
and right sides of this DNA fragment were mapped and colored.
In addition to the use of short fragments, a signal to noise ratio threshold is sug-
gested for datasets suitable for footprints, where the signal is reads mapping to genomic 
regions within DHS, and noise is reads mapping to genomic regions not in DHS (Vierstra
& Stamatoyannopoulos 2016).  Signal to noise was calculated as the percentage of reads 
within DHS (percentage: # reads in DHS / # reads not in DHS).  These percentages are 
shown in a table for each read sets B1-B4.  For this signal to noise, the percentage of 
reads within a set of previously discovered DHS (Ling et al. 2010) were calculated. For 
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each of the specified read sets, the percentage of reads within DHS are presented in Table
1. These reads that were within a DHS are presented in Table 1. For read sets B1 and B2, 
B1 represents all read lengths NTs < 125, and B2 represents the set of longest reads hav-
ing a count of n reads where n was the number of reads within B1.  B3 and B4 were the 
shortest and longest 1/3rd of reads respectively.  Each read set was interrogated for signal
to noise as specified.
Section 3.3.6  Sequence read datasets
For all ChIP-Seq datasets used to benchmark msCentipede and the straw man model in 
human cell line GM12878 were downloaded from the UCSC genome browser.  These 
ChIP-Seq binding sites were all part of the ENCODE project and were downloaded from 
the UCSC genome browser using the “Track Search” option: Cell, tissue or DNA sample 
GM12878, experiment ChIP-Seq.  Sequence reads used for chromatin for the assay 
DNase-1 were downloaded from GEO GSE29692, DNase-I naked genomic DNA from 
human cell line IMR90 was downloaded from GEO GSE18927, and corresponding 
ATAC chromatin for human cell line GM12878 GEO GSM1155961  and naked genomic 
DNA from cell line NA18507 was downloaded from the Sequence Read Archive 
SRP004087.
3.4  Results
3.4.1  Sequence bias of DNase-I and the Tn5 transposase
The sequence bias of DNase-I has been previously described (Lazarovici et al. 
2013; Koohy et al. 2013).  From these studies, a well described bias of DNase-I for 
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cutting at hexamers was presented.  Specifically, cuts made by DNase-I are enriched for 
hexamers comprised of sequences 3 nts up and downstream from a cut.  The hexamer 
spanning the cut site therefore represents a proposed 6 nt recognition site for the 
endonuclease.  This cutting preference was used in my enrichment analysis to quantify 
the sequence bias of DNase-I.  This enrichment of hexamers for cutting by DNase-I 
describes the affinity of DNase-I for cutting specific nucleotide sequences.  This 
sequence bias of cutting therefore has the potential to confound footprint-calling 
algorithms, which analyze the signal generated by cut site locations from released DNA 
fragments, and are built to explain perturbation of this cutting due to TF-DNA 
interaction.  If these algorithms are to accurately predict of TF-DNA interactions, the 
DNase-I signal must not be the result of a biased signal due to DNase-I sequence 
preference, but instead by true TF-DNA interactions.
Like DNase-I, Tn5 transposase cuts DNA in open chromatin, and is therefore a candidate 
fragment release method in the context of digital genomic footprinting (DGF) (Davie et 
al. 2015; Buenrostro et al. 2013).  Here, I quantified the enrichment of hexamers 
representing proposed sequence recognition sites spanning cut sites for DNase-I and Tn5 
separately.  For each fragment released by either assay, a cut site was mapped at one end 
of a released fragment (Materials and Methods).  For all fragments released, all hexamer 
sequences spanning 3 nts up and downstream from the cut were counted.  For all 4,096 
possible hexamers, a count was assigned.  A fold change of counts observed vs expected 
was then calculated.  I used a whole-genome scan for hexamers to represent the expected 
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count for hexamers.  The expected number of hexamers was this count normalized to the 
number of reads in the sample.  The observed hexamer count vs expected represented a 
fold change enrichment (FC) (Materials and Methods).  The fold change for all 4,096 
possible hexamers is plotted in Figure 3.1.  Enrichment is plotted on a log2 scale, where 
y=log2 FC of observed hexamers vs expected, for all possible hexamers.  For each 
fragment release method, hexamers were ranked by FC and plotted separately: for each x 
axis position, the fold change plotted is for a different hexamer, with black representing 
DNase-I and red ATAC.
DNase-I and Tn5 showed strong sequence preference for cutting at hexamer sequences.  
This bias was up to ~500 fold.  Therefore, sequence reads from the ATAC-seq method 
yielded a sequence-biased signal similar to that for DNase-I.  This sequence-biased signal
therefore may mask effects produced by TF-DNA interactions.  While different hexamers
represent different sequence preferences as defined above, the extent of cutting bias is 
similar.
The considerable cutting bias of DNase-I is illustrated in Figure 3.1, and also was found 
in previous studies.  This cutting bias may confound footprint calling algorithms that rely 
on signal from mapped cut sites to predict TF-DNA interaction.  A TF-DNA interaction 
should ideally yield a specific signal at a binding site.  Any signal resulting from the 
sequence bias of DNase-I is irrelevant to observing a footprint.  Footprint algorithms 
must make this distinction.  To visualize the effect of sequence bias on footprint 
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detection, three plots of cut site signal for several TFs are shown in Figure 3.2, for 
fragments released by DNase-I and Tn5.  For this analysis, publicly available data for the 
human cell line GM12878 is used.  Each plot shows average cutting for the genomic 
region spanning 100 nts up and downstream from a TF binding motif (Materials and 
Methods).  For chromatin plots marked BOUND and UNBOUND, motifs were 
partitioned into bound and unbound status as determined by corresponding ChIP-seq 
experiments.  For these plots, either DNase or ATAC-seq experiments were carried out 
(marked CHROMATIN, black).  The plot marked GENOMIC shows signal generated 
using the same unbound motifs, however the signal of cut sites generated from DNase-I 
or ATAC seq was from a library prepared from purified genomic DNA.  The third plot 
therefore shows signal from DNA having no bound protein.  These plots demonstrate that
any signal is completely explained by the sequence preferences for of cutting alone.  
These visualizations clearly illustrate the challenges that a footprinting algorithm tasked 
with separating bound vs unbound motifs will face (Supplementary Figure 2).
For both sets of plots in Figure 3.2, profiles within the motifs are seen to be similar while 
for bound and unbound motifs there are obvious differences in signal patterns flanking 
the motif, and any footprint-calling algorithm would be challenged to detect significant 
differences in signal for bound vs unboud motifs using signal within the motif.  Further, 
profiles generated from fragments released by cleavage of purified (naked) DNA (“ge-
nomic” samples) showed a similar pattern:  there is no obvious difference in profile be-
tween bound motifs and motifs completely free from TF interactions.  The cut site profile
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within the motif therefore results from sequence bias of the enzyme.  Further, like that of 
DNase-I, fragments generated from the ATAC-seq method varied ~500 fold in cutting at 
different sites.  ATAC-seq profiles therefore exhibit  sequence bias to a similar extent as 
observed for DNase-I.  The intrinsic sequence bias shown here may limit the potential of 
ATAC-Seq for calling real footprints.  While previous studies have presented ATAC-seq 
as a possible alternative to DNase-seq because it is a simpler assay, it also has the se-
quence bias issue, and may therefore not be a viable alternative to DNase-I digestion for 
detection of TF footprints.
3.4.2  Performance of footprint calling: DNase-I vs ATAC-Seq
As discussed above, DNase-I and Tn5 transposase have an intrinsic sequence bias for 
cutting, and this bias may adversely affect the ability of computational methods to call TF
footprints.  Many footprinting algorithms have been published, and these have been used 
to predict TF binding sites (Gusmao et al. 2016).  Many of these methods make attempts 
to correct for this sequence bias.  I chose to use PIQ, an algorithm that calls motifs as 
footprints according to signal generated from cut sites from sequenced DNA fragments 
(Sherwood et al. 2014).  While PIQ makes no intrinsic sequence bias correction, Gusmao 
et al found this algorithm comparable to other top performers (Gusmao et al. 2016).  
Here, PIQ was used to analyze reads from DNase-I and ATAC experiments on the human
cell line GM12878.  For a set of 31 TF motif locations determined by a motif scanning 
module supplied by the PIQ software, I ran the PIQ footprint-calling algorithm using 
DNase-I and ATAC reads separately.  Footprints were called using PIQ using the default 
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cutoff.  Those motifs called as footprints were then compared to corresponding “gold 
standard” binding sites determined by corresponding ChIP-Seq experiments (ENCODE). 
Each called footprint was therefore from either a “true” binding site, or an unbound site.  
This label was used to evaluate the performance of the PIQ algorithm for the 2 assays.  
The performance measure was the percentage of called footprints discovered at 
corresponding true binding sites for a TF.  The performance of DNase-I and ATAC-seq 
methods for finding true footprints using the PIQ footprint-calling algorithm are 
summarized in Figure 3.3.
These plots show that neither DNase-I nor ATAC performed particularly well, with most 
TFs scoring well below 30 percent.  It would appear that the footprinting algorithm failed
to make calls at “real” binding sites, except for CTCF, where DNase-I showed strong 
evidence for TF-DNA interaction by PIQ analysis 90% of the time.  Further, individual 
TFs had different performance for the two methods.  Recently, this observation was 
linked to the residence time of certain TFs in DNA binding.  Detectable footprints made 
by TF-DNA interaction may depend on the amount of time the TF spends in contact with 
DNA (Sung et al. 2016).  While it may eventually be possible to show a correlation 
between footprint-calling performance and residence time, this information is not 
available for all TFs.  
There was no clear performance difference between DNase-I and ATAC.  For 
most TFs, the ATAC method seemed to out-perform DNase-I.  However, for CTCF and 
TBP, DNase-I was a clear winner.  It may be possible that for these corresponding motifs,
CTCF and TBP show limited sequence bias for DNase-I has less sequence bias for CTCF
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and TBP motifs compared to ATAC.  It may follow that for certain families of TFs, 
DNase-I will out-perform ATAC, or vice versa.
3.4.3  Performance of footprint calling: Stat5 high and low status
DNase-seq reads from 5 individual male mouse livers from this laboratory as well as 4 
corresponding individuals from available ENCODE data sets , along with genomic loca-
tions of transcription factor binding motifs, were used as input to the msCentipede foot-
print calling algorithm (Raj et al. 2015).  I used msCentipede for this analysis as it be-
came available at the time of this writing, and for it's promise to use purified naked DNA 
as a background in order to control for sequence bias within the motif, however, for tech-
nical reasons this feature was not used.  The results were then benchmarked using ChIP-
seq information for each TF.  For each input motif location, msCentipede assigned a 
score that represented the probability of TF-DNA interaction.  The footprint score was 
used as the ranking element for plotting the ROC curve, with any given motif having a 
higher score than all others below it.  All motifs were sorted by the footprint score calcu-
lated by msCentipede, flagged as bound / unbound, and ROC plots were generated (Fig-
ure 3.5).  The area under this curve (AUC) represented a standard performance measure 
for the tool.  Additionally, the msCentipede algorithm was compared to a much simpler 
model.  This simple “straw man” model (SM) called footprints at motifs within open 
chromatin: motifs were called based on chromatin “open-ness” alone.  Because this rep-
resents the simplest model for assigning TF binding probability, any footprint-calling al-
gorithm must  out-perform the SM model to justify more complex models (Supplemen-
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tary Figure S3.3).  Table 3.2 shows results for the msCentipede algorithm and the straw 
man model for both sets of WAX and ENCODE reads from STAT5 high status livers.  
Strikingly, the SM model performed similarly to the more complicated msCentipede 
model, and in some cases it was the winner.  This result implies that the use of msCen-
tipede or similar tools may not be justified.
3.5  Discussion
Digital genomic footprinting has met much controversy (Anon 2016; Sung et al. 
2016; Vierstra & Stamatoyannopoulos 2016; He et al. 2013).  What started as a proof of 
concept for a technique yielded many subsequent algorithms aiming to call footprints at 
individual genomic locations (Boyle et al. 2011; Hesselberth et al. 2009).  Most 
footprinting techniques thus far have used DNase-I to release fragments, a technique with
a well characterized sequence bias that can explain signal within motifs (Lazarovici et al. 
2013).  Recently, an alternative DNA fragment release method called ATAC-seq 
promised a much simpler assay to release fragments of open chromatin (Buenrostro et al. 
2013).  While this technique has been used to perform digital genomic footprinting in 
primary human T cells, benchmarking of the called footprints is limited, and the utility of
this assay vs. DNase-Seq is not yet clear (Qu et al. 2015).  Here, I show that performance 
of both assays is TF dependent.  Indeed, for a particular TF, one assay may have better 
coverage or higher signal to noise ratio, and these factors may give an advantage to of the
assays.  However, there was no consistent bias for one assay over the other.  
Additionally, each TF may have properties favorable to footprinting in general, such as 
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residence time, that can explain footprinting performance for a TF, eg CTCF (Sung et al. 
2016).  The difference in performance between DNase-I and ATAC for certain TFs 
remains to be determined.  With current information and the data sets I have analyzed 
here, the difference between assays is insignificant compared to the overall low 
performance of both.  Thus, without better data or better analysis tools, using ATAC-seq 
instead of DNase-seq cannot be recommended.
Using our own data for muse liver, as well as data from the ENCODE project, the 
algorithm PIQ was able to perform well according to AUC of ROC figures (ranging from
~50% to 78% for our data, and 78% to 99% for ENCODE reads).  Surprisingly, though, 
there was no clear difference between the performance of PIQ compared to a much 
simpler “straw man” approach.  While it has been claimed that PIQ outperforms simpler 
models, for our data and our performance benchmarking this was clearly not the case 
(Sherwood et al. 2014; Gusmao et al. 2016).  My analysis shows that PIQ was not robust 
enough to out-perform the straw man  model, and for purposes related to research in the 
Waxman lab, the utility of DGF was limited.
Vierstra and Stamatoyannopoulos recommended that shorter DNA fragments and high 
signal to noise (length < 125 nts, 50% reads in DHS peaks) would lead to more robust 
footprint determination (Vierstra & Stamatoyannopoulos 2016).  Using these guidelines, 
they showed convincing footprints at single genomic locations.  These footprints appear 
to be real when observing signal within motifs compared to the expected signal from 
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sequence bias alone.  These findings make a good argument that the digital genomic 
footprints are indeed real, and that using smaller DNA fragments can yield results with 
better signal to noise and superior footprints.  From our data, however, it was not 
immediately clear if better results will come from sequencing of smaller DNA fragments,
as smaller fragments from an in silico selection of available data yielded only slightly 
better signal to noise.  In Table 3.1, the percentage of reads in peaks for “short” and 
“long” versions of read sets (Materials and Methods) are presented. From these reads 
partitioned by length, the difference in percentage of reads in peaks is most different for 
reads within vs not within the guidelines set by Vierstra and Stamatoyannopoulos (Set B1
vs Set B2, Table 3.1), however, these results are not striking.  Further, the longest 1/3rd 
and shortest 1/3rd have zero effect on the percentage of reads in peaks for these data.  I 
therefore concluded that it is ill-advised to pursue sequencing of small fragments from 
our experimental samples in efforts to improve footprintinge efforts, as the guidelines for 
read length did not show an improvement for the percentage of reads in peaks.
Cumulative plots for motifs within “high occupancy and accessibility” regions show clear
evidence of true footprints in comparison to “low or no occupancy and accessibility” 
regions for AP-1 and many others (Vierstra & Stamatoyannopoulos 2016).  While clear 
footprints for motifs within high accessibility regions are apparent, no comparison is 
shown for motifs that are known to be TF bound vs unbound.  It is therefore not clear if 
footprint information significantly improves a model that simply calls footprints at “high 
accessibility” regions.  In my work, I found that while PIQ does a good job of finding 
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footprints, this algorithm did not out-perform a much simpler “straw man” model. 
It is possible, however, that true footprints exist, and that TF-DNA interaction is observ-
able within the context of DNase-Seq data analysis.  For a handful of examples, it is pos-
sible to observe what may be interpreted as footprints when observing genomic regions 
of high accessibility and high levels of TF binding (Supplementary Figure S3.5).  These 
observations, and and observations by  Stamatoyannopoulos and co-workers, show that 
while true footprints may exist, the current state of the art is not adequate to make such 
predictions.
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Figure 3.1:  Fold change of observed vs. expected hexamers spanning DNase-I and 
the Tn5 transposase cutsites.  Log2 FC (Materials and Methods) of observed vs 
expected numbers of hexamers is plotted for DNase-I and Tn5 transposase digestion of 
purified genomic DNA from human cell lines (He et al. 2013; Grøntved et al. 2012) .  
The background represents the number of hexamers within the genome.  Each hexamer is
sorted by FC on the x axis.  This is done separately for DNase-I (black) and Tn5 (red).  




Figure 3.2:  Cumulative plots for chromatin and purified DNA, ATAC and DNAse-
Seq methods.  Cumulative plots of cutting at bound / unbound PBS with chromatin and 
purified genomic DNA for 2 TFs. A)  Cumulative cutting patterns for ATAC and DNase-
I fragment release methods for CTCF. B)  Corresponding plots for EBF1.  For both plots,
similar patterns are observed at bound and unbound PBS.  Further, the purified genomic 
DNA  shows a similar pattern across fragments released from chromatin and purified 
genomic DNA.
A.  Cumulative plots for CTCF
B.  Cumulative plots for EBF1
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Figure 3.3:  Performance of PIQ for datasets DNase-I and ATAC.  Performance of 
the PIQ footprinting algorithm for datasets generated from the DNase-I seq and ATAC 
seq methods across a set of 31 TFs. For each of the 31 TFs, footprints are called at 
corresponding motif locations.  These motifs are either at or not at a “gold standard” set 
of binding sites determined by ChIP-Seq (ENCODE).  The performance of the PIQ 
algorithm for datasets from DNase-I and ATAC sequencing are shown.  The performance
is a percentage of called footprints at real binding sites.
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Figure 3.4: Distribution of DNA fragment size for paired end reads.  DNA fragment 
size distribution is shown for sample G82-M1.  Here we see that the median DNA 
fragment size released by DNase-I is around 220.  For this sample, only a small fraction 
of reads are in the range deemed appropriate by Stam (2016) (~125 bps).  For paired end 
sequencing, the start and end of each DNA fragment is mappable, and in this way, DNA 
fragments can be size selected in silico.
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Figure 3.5: ROC curves for msCentipede and “straw man”   Below are ROC curves 
for all analyzed TFs with corresponding AUC values indicated in each figure legend.  
Shown is the true positive rate and corresponding false positive rate for each false posi-
tive rate (x axis) using benchmarking results from all motifs for each TF separately.  Re-
sults from the algorithm msCentipede algorithm as well as the much simpler “straw man”
approach outlined in Section 3.4.3 where each motif is benchmarked using only chro-
matin availability.
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Table 3.1: Percentage of reads in DHS: short vs long DNA fragments.  Table 1: Per-
centage of reads in DHS for short and long read sets.  For B1,B2, only reads that have 
length < 125 are included in the short set.  The long set includes the longest reads with 
the same number of reads as the short set.  In this way, the shortest and longest reads are 
partitioned while keeping the number of reads constant.  For B3, B4, the shortest 1/3rd 
and longest 1/3rd represent the short and long sets respectively.  For these sets, the num-
ber of reads included in the analysis is much greater, and a comparison between short and
long reads is possible.
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Table 3.2:  AUC for msCentipede algorithm and straw man model (SM)
AUC values for Waxman lab reads and ENCODE, high STAT5 status read set.  Reads 
from the Waxman lab read set and ENCODE were used for the msCentipede algorithm 
and for the SM model.  AUC values for the ROC are reported.  For both Waxman lab and
ENCODE reads, there is no obvious difference between the msCentipede algorithm and 
the straw man model, showing that for these reads, msCentipede may not be a justifiable 
algorithm for making TF binding site predictions.  For those TFs that have no AUC for 
msCentipede, these values were missing due to technical issues and not because of 
differences in AUC values.
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Supplementary Figure S3.1: Hexamer sequence recognition of DNase-I and the Tn5 
transposase Shown are the published sequence recognition sites for DNase-I 
(Lazarovici et al. 2013) and the Tn5 transposase (Madrigal 2015).  Both DNase-I and the 
Tn5 transposase had sequence preference of cutting for 3 nt up and 3 nt downstream from
the cutsite.  The enrichment of cutting for each possible hexamer was calculated (Materi-
als and Methods) and plotted (Figure 1).
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Supplementary Figure S3.2: Cartoon diagram showing the proposed model for de-
tecting footprints. This diagram shows the proposed model for detecting footprints.  
Illustrated are average signal generated from cumulative cuts sites generated from 
DNase-seq and ATAC-seq libraries anchored at a specific motif (TTC-NNN-GAA).  This
diagram shows that, according to the hypothesis laid out in the DGF technique, there 
should be a detectable footprint for bound motifs within motifs for fragments released 
from chromatin, where there is no footprint for unbound motifs.  Additionally, for puri-
fied genomic DNA, no proteins are bound to the DNA, and there should be no perturba-
tion in signal as seen for bound chromatin motifs.  Any signal observed for unbound ge-
nomic DNA must therefore be explained not by TF-DNA interaction, but by some other 
mechanism such as sequence preference in cutting.
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Supplementary Figure S3.3: Ranking metrics and performance evaluation.  Shown 
is a schematic of how footprint calling methods were benchmarked.  The “ranking met-
ric” was either generated from the tool being interrogated or my own “straw man” 
method.  Motifs are ranked by this metric.  Each motif is called as bound or unbound by 
using corresponding ChIP-seq experiments as a “gold standard.”  True positive and false 
positive rates (TPR, FPR) are calculated for each motif with all motifs having a higher 
rank called as a footprint. From these TPR and FPR, the area under the receive-operator 
curve (AUC of ORC) is given as the performance measure.
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Supplementary Figure S3.4: Released fragment size distribution of male mouse liver
samples. Shown are distributions summarized into a table for male liver samples 
from the Waxman lab of the G155 and G18 series used in this study.
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Supplementary Figure S3.5 Screenshots of cutsites for different size fragments sur-
rounding the Albumin gene. Many TFs are bound to DNA around the Al-
bumin gene for mouse.  Shown are cutsite locations within a region surrounding this 
gene.  Given separately are cutsites generated from “small, medium and large” fragment 
sizes (shortest 1/3rd, middle 1/3rd and longest 1/3rd).  This figure demonstrates the po-
tential differences one may observe for different fragment sizes where many TFs are 
bound indicated by the PEAKs track (TF binding sites determined by ChIP-Seq). 
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CHAPTER 4 – Translational regulation in mouse liver studied by sequence analysis 
of ribosome protected fragments
4.1 Abstract
Sex differences in liver gene expression are widespread, as indicated by analysis of 
mRNA levels, and are thought to be largely controlled by transcriptional and epigenetic 
regulatory events. Here, we used ribosome profiling by Ribo-seq to determine whether 
translational regulation contributes to sex differences in gene expression in male and 
female mouse liver. Ribo-seq detects and quantifies RNA sequences bound by ribosomes 
engaged in protein translation in the cytoplasm. The apparent translational efficiency 
(TE) of liver-expressed RNAs was determined by comparing Ribo-seq and matched 
whole liver RNA-seq datasets for adult male and female mouse liver. Liver-expressed 
RNAs showed a wide range (>30-fold) in TE, which was positively correlated with 
transcript abundance, and in the case of many very low TE RNAs was associated with 
nuclear localization, where RNAs are unavailable for ribosome binding. Sex-biased genes
showed a similar range of TE values as correspondingly expressed sex-independent 
genes; further very few genes showed sex differences in TE, indicating that translational 
regulation does not contribute appreciably to liver sex differences. 5'-untranslated regions
having a translated open reading frame were shown to decrease TE, consistent with their 
interference with translation initiation. Finally, RPFs identified within short open reading 
frames were discovered in a subset of liver-expressed lncRNAs, including for sex-biased 
lncRNAs, suggesting that novel peptide sequences with biological function are translated 
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from these otherwise non-coding RNAs. 
4.2 Introduction
The central dogma of molecular biology, that is, the process by which DNA is decoded 
into functional proteins, involves the elongation of peptides (Crick 1970). Specifically, 
this elongation involves ribosomes which engage messenger RNA (mRNA) within the 
cytoplasm. The ribosome complex reads each codon within the mRNA, and 
corresponding amino acids are joined in sequence, forming the complete peptide. 
Recent advances in sequencing technology have allowed the measurement of abundance 
of mRNA within the cell (Wang 2001). The abundance of mRNA has been used as a 
proxy for the expression of a gene, via RNA-seq technology. However, proteins, and not 
mRNA transcripts, generally carry out cellular functions, and so transcript abundance 
only approximates protein levels, as the translation process and protein stability 
ultimately determine cellular protein levels. Ribo-seq sequences ribosome-engaged 
mRNA, or mRNA protected by ribosomes (ribosome protected fragments, RPF) (Ingolia 
2016). These sequence reads identify ribosome-bound transcripts genome-wide at 
nucleotide (nt) resolution (Figure 4.1). Ribo-seq therefore provides a quantitative 
genome-wide snapshot of which transcripts are under active elongation.
Here, I investigate whether the well-studied sex differences in transcription of genes, 
measured by whole liver RNA-seq, are modulated by sex differences in RNA to protein 
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translation, as measured by Ribo-seq. Liver Ribo-seq, along with whole liver RNA-seq 
experiments performed by Dr. Pengying Hao of this laboratory, yielded mouse liver RPF 
and RNA-seq datasets, which were used to quantify translation and transcription genome-
wide. I used datasets for male and female mouse liver to investigate sex differences in the
efficiency of translation of genes. Using the two assays together, the abundance of 
transcripts within the cell was compared to the abundance of transcripts under active 
elongation to estimate an apparent efficiency of translation (translation efficiency, TE) 
for all expressed genes. 
From translated mRNA to fully formed peptide, genes may have widely differing TE due 
to outside stress (Zid & O’Shea 2014). TE can also be modulated by diverse molecular 
mechanisms involved in elongation (Gebauer et al. 2012; Selbach et al. 2008). In another 
study involving mouse liver, TE values ranged from roughly 12% to >100% (TE ~ -2 to 
TE > 0) (Janich et al. 2015). Mechanisms proposed for this large range of TE include 
interference by ribosomes bound to short coding regions within upstream open reading 
frames (Morris & Geballe 2000). Here, mouse livers were interrogated for sex differences
in TE. Few significant sex-differences in TE were detected. Additionally, TE values 
obtained for sex-specific genes defined by whole liver RNA-seq were compared to those 
from comparably abundant and localized sex-independent genes. Sex-specific genes were
comparably efficiently translated compared to corresponding similarly localized and 
abundant sex-independent transcripts, indicating that sex-differential transcript 
abundances correspond to predicted protein levels comparable to that of the stated 
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corresponding genes in mouse liver.
Molecular mechanisms for the modulation of TE by translation within the 5' UTR of 
transcripts have been proposed (Morris & Geballe 2000; Johnstone et al. 2016; Calvo et 
al. 2009). 5' UTRs are those regions within the 5' end of transcripts annotated as non-
coding, and are located upstream of coding genes. ORFs have the potential to code for 
peptides and are often found within 5' UTRs of genes. These uORFs are components of 
molecular models explaining TE. Different uORFs were shown to affect TE for upstream 
genes. These models involve the interference of translating ribosomes within uORFs that 
physically block ribosomes from translation initiation at the translation start site. Here, 
the TE for genes with and without uORFs were determined. Genes with uORFs were 
found to have significantly lower TE. However, a bias for nuclear localization of genes 
with uORFs may explain some of the observed TE difference, as nuclear localization of 
transcripts was shown to bias TE. Further, the algorithm ribORF provided evidence of 
translation for some uORFs (Ji et al. 2015). Genes with translated vs untranslated uORFs 
indeed showed diminished TE. This lower TE for genes with translated uORFs supported
the model of translated uORFs modulating TE of downstream genes. Finally, we use RPF
analysis to identify short peptide-coding sequences within ~15,000 liver-expressed 
lncRNAs, including several lncRNAs that show sex-biased expression at the RNA level.
4.3 MATERIALS AND METHODS
4.3.1 Library preparation for Ribo-seq and whole liver RNA-seq, with nuclear and
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cytoplasmic fractions 
In wet lab work conducted by Dr. Pengying Hao of this laboratory (Pengying Hao PhD 
Dissertation, Section 5.E Methods), livers were harvested from n=10 adult mice (5 males 
and 5 females). Sequencing libraries for Ribo-seq and whole liver RNA-seq analysis 
were prepared for each individual liver separately, yielding liver-paired datasets of RPF 
and RNA-seq reads for each of the 10 livers. Raw sequence data for all sequencing 
libraries samples (sequencing samples series numbered G148 and G149) are available at 
GEO accession GSE119614. Additionally, liver RNA-seq libraries from a separate set of 
male and female mouse liver were prepared from cytoplasmic and nuclear cellular 
fractions. For these samples, 2 livers were sequenced for each fraction separately for 
males and females, yielding a total of 4 additional liver RNA-seq libraries. These 
libraries were used in all analyses that sought to establish genome-wide nuclear vs. 
cytoplasmic localization of genes. These samples are available at GEO accession 
GSE119614. 
4.3.2 Read processing and mapping
Libraries for all experiments were sequenced using the Illumina platform. The resulting 
FASTQ files for each sample were checked for read quality and adapters using FastQC 
(Andrews 2018). Ribo-seq reads were trimmed to remove standard Illumina adapters 
from each read by searching the first 13 nt of adapters using the Trim Galore algorithm 
(Kruger, 2015), which yielded sets of reads with a median length 30 nt. To avoid bias in 
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read mapping, the 50 nt read sets for the whole-liver RNA-seq samples were trimmed 
using Trim Galore to match the length of reads in the Ribo-seq libraries. Reads were 
mapped to the mouse genome (mm9) using the Bowtie 2 algorithm (Langmead & 
Salzberg 2012) and an in-house pipeline designed by Andy Rampersaud and Dr. Tisha 
Melia of the laboratory (Lodato et al. 2017). Mapped reads were processed using the 
ribORF algorithm as described in the ribORF documentation (Ji et al. 2015). Briefly, 
RPFs were combined for male and female livers, and reads were adjusted to show the 
location of the active site within the ribosome, reflecting the location of the first nt of the 
codon within the mRNA, as opposed to the first nt of the released fragment. By 
visualizing the 3 nt periodicity for sets of fragments having length ranging from 28 to 31 
after adapter trimming, the distance from the edge of the released protected fragment (5' 
side of fragment) and the ribosome A-site was observed by visualizing the genomic 
location where 3 nt periodicity begins. For each set of fragments with lengths 28-30, this 
offset distance was 15. This was done in accordance to the guidelines within the ribORF 
analysis pipeline. ribORF uses the processed libraries to create a .BAM file that 
represents the first nt in the read which, upon visualization using tools within ribORF, 
shows, at nt resolution, precisely where the ribosome is bound and protects the mRNA 
from nuclease digestion during RPF sample preparation.
4.3.3 Mouse genome annotation: Coding genes, 5' UTR
Gene expression analysis used a set of 24,197 previously defined RefSeq transcripts 
assembled from the mouse (mm9) genome (Lodato et al. 2017). Reads from each 
99
sequence library were mapped to the mouse genome, and expression levels of each 
mRNA were quantified by counting reads within a specified set of genomic locations 
(general feature format, GTF file) using the featureCounts tool (Liao et al. 2014), which 
counts reads mapping to transcripts within regions specified by the GTF file 
(Supplemental Table 4.UTR_GTF, available upon request). GTFs were compiled using 
RefSeq annotated genome locations. The GTF annotated for coding genes only included 
regions within exons, and excluded any region that overlapped 5' or 3' UTRs from any 
isoform from any gene defined by any RefSeq (“exon no UTR” GTF). This annotation 
was done to eliminate potential bias of increased signal for whole liver RNA-seq read 
sets. Whole liver RNA-seq libraries included reads within 5' and 3' UTRs of transcripts, 
while RPFs did not, as the majority of UTRs are not translated. For 5' UTRs, this GTF 
was defined as RefSeq annotated 5' UTRs that do not overlap with coding regions from 
any gene or isoform of the corresponding gene. This yielded a conservative set of 5' 
UTRs that did not overlap any coding region, regardless of isoform (Supplemental 
Table , S4.EXON_NO_UTR).
 
4.3.4 Characterization of liver transcriptome and translatome
Sequence reads generated from the RNA-seq and Ribo-seq platforms mapped to 
transcripts were quantified using the transcripts per million (TPM) normalization method.
For each gene, TPM normalizes the read counts by first defining the transcripts as reads 
per unit gene length (1,000 bp, kbp). The transcript count is multiplied by a scaling factor
of 1 million, then divided by the total number of transcripts for all genes. I calculated 
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TPM signal for 5 male and 5 female livers for both whole liver RNA-seq and Ribo-seq. 
TPM from whole liver RNA-seq represents the number of transcripts per gene, or 
transcriptome, TPM calculated from Ribo-seq represents the number of RPFs per gene, or
translatome. For the transcriptome and translatome, genes were defined as liver-
expressed if the average TPM from all whole liver RNA-seq samples (all 10 samples, 
males and females) was > 1.
4.3.5 Genome-wide nuclear / cytoplasmic localization
Nuclear and cytoplasmic libraries for 2 male and 2 female mouse livers were used to 
calculate, genome-wide, a nuclear to cytoplasmic ratio (N to C ratio). For each gene, the 
N to C ratio was defined as log2(TPM nuclear / TPM cytoplasmic). A single pseudocount
value, which equals the lowest cytoplasmic TPM across all 4 male / female livers, was 
added to all TPM values of each liver for the cytoplasmic fraction to avoid dividing by 
zero (pseudocount TPM value ~ 0.0104). The N to C ratio therefore defined each gene's 
bias toward having nuclear localization (high N to C values = highly nuclear genes). N to 
C ratios were calculated for each liver. The average N to C value for male and female 
livers was calculated. The average N to C value calculated for all 4 liver samples was 
assigned to each gene (Supplementary Table S4.NC_RATIO).
4.3.6 Translational efficiency of genes
TPM values for each gene were determined for the translatome and the transcriptome, 
and then were used to estimate the efficiency of translation (TE) for transcripts genome-
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wide. TE was calculated for each annotated gene from TE=log2(RPF/FOXA2RNA-caseinseq), where 
RPF is the TPM calculated from RPF data, and RNA-seq is the TPM calculated from 
reads from the whole liver RNA-seq platform. To normalize the TE figures, RPF TPM 
values were transformed so that the average ratio of RPF / RNA-seq TPM was 1 
(Materials and Methods, 4.3.12). This model for quantifying the TE has limitations, 
specifically for genes with a measurable RPF signal whose whole liver RNA-seq signal 
was 0. In this case, because the mRNA within the cell was undetected, any signal from 
RPF is interpreted as a false positive. To allow for the biologically relevant case of zero 
signal from RPF for genes having signal from whole liver RNA-seq, a single 
pseudocount value was added to the RPF read set for each gene: the lowest TPM value in
male or female liver was added to TPM values for all genes for each male and female 
liver, to insure that all genes from all RPF datasets have TPM > 0 (pseudocount 
=3.951x10-4 ). Also, for each gene, I calculated the number of male livers, and separately 
the number of female livers, for which the whole liver RNA-seq signal > 0, in which case
the log2(RPF/RNA-seq) yields a finite TE value.
The log2 ratio of signal from RPF vs RNA-seq presented cases where the whole liver 
RNA-seq signal was zero, yielding a non-finite TE value. Therefore, for each gene, the 
sets of 5 male and 5 female livers had a range of finite TE values from 0 (no livers with 
finite TE values) to 5 (all livers with finite TE value). This range of 0 to 5 finite TE 
values for each gene represents a “degree of freedom” (DF) for each gene for each read 
set (5 male livers, 5 female livers). For each comparison of TE values for male or female 
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livers, only genes with a minimum DF = 3 for that dataset were included in the analysis, 
except as noted otherwise.
4.3.7 Sex differences in TE
The difference in male liver TE vs female liver TE was calculated for each gene within 
log2 space: sex Δ TE = male TE – female TE; thus, a sex Δ TE value > 0 indicates a 
higher TE in male than female liver. The significance in sex Δ TE was determined using 
a t-test for genes with ≥ 3 finite TE values in both males and females (DF ≥ 3) to increase
the statistical power for the t-test determination. A false discovery rate was calculated to 
correct for multiple hypothesis testing using the Benjamini-Hochberg method (Benjamini
& Hochberg 1995), where all P-values were tested using the p.value method in R with 
option “bh” for multiple testing method.
4.3.8 TE of sex-specific genes 
Differential TE of sex-specific genes vs sex-independent genes was also investigated. For
male and female livers separately, TE values of sex-specific genes were compared to 
those of sex-independent genes. Genes were identified as sex-specific when the sex 
difference in gene expression from whole liver RNA-seq was > 2 fold at adjusted P-value
< 0.05, as determined by EdgeR. This produced a set of 201 male-specific and 239 
female-specific genes. Sex-specific genes were divided into 4 bins based on their whole 
liver RNA-seq TPM values, which represent the abundance of mRNA in the cell, to 
control for artifacts that may arise from the apparent dependence of TE on transcript 
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levels. The sex-independent gene set had a stringent requirement of having a sex-
difference fold change < 1.2, and an FDR > 0.1, which yielded a set of 17,635 stringent 
sex-independent genes. To compare TE values of sex-specific genes to those of sex-
independent genes, each sex-specific gene was matched to a set of corresponding 
stringent sex-independent genes, defined as having comparable whole liver transcript 
abundance (TPM) and comparable N to C values to that of the sex-specific gene (± 0.7 
log2(TPM for whole liver) and (± 0.7 log2(N to C values)). From this set, the average TE
served as an approximate TE value for the set of stringent sex-independent genes that 
corresponded to each sex-specific gene. This was done for all genes in all bins. The TE 
values of sex-specific genes were compared to the approximate TE values from the 
stringent sex-independent set. To establish significance in differences of TE for each bin, 
the TE of sex-specific genes in each bin were compared to corresponding approximate 
values from sex-independent genes using a t-test.. As each gene set used in 
approximating the TE of corresponding sex-independent genes required each of these 
genes to be within a reasonable range of the sex-specific genes, the N to C ratios of the 
sex-specific genes were compared to those of the sex-independent genes. The N to C 
ratios of sex-specific genes, together with corresponding average N to C ratios from the 
stringent sex-independent genes, were, also compared to demonstrate that the TE values 
are not an artifact of cellular localization. 
4.3.9 uORF mapping, ribORF algorithm
ORFs were identified in 5' UTRs using the TransDecoder tool (Haas et al. 2014). This 
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tool takes as input a genome transfer format (GTF) file and a genome (mm9), which was 
scanned for ORFs, defined as regions between conventional start and stop codons 
satisfying a minimum length. These ORFs were determined for genomic regions 
specified by the GTF. The minimum codon length for a uORF was set at 9 codons (27 
nt). Transcripts of this length, while short, may be biologically relevant, and have been 
previously characterized as smORFs ranging from 10-100 codons (Couso & Patraquim 
2017). Further, uORFs were required to have zero overlap with exons from any gene, 
including all isoforms derived from the corresponding gene. This requirement ensured 
that uORF regions were truly not translated according to the RefSeq annotation. ribORF 
was given GTFs for annotated UTRs described above (see section 4.3.4) as input, 
yielding sets of uORFs within the defined 5' UTRs. In addition, TransDeoder was used to
flag each uORF as complete or 3' partial. Complete uORFs have start and stop codons 
completely within the 5' UTR; 3' partial uORFs continue into the translation start site, 
i.e., the uORF is not terminated by a stop codon but rather extends into the gene body. 
However, only the region within the 5' UTR was used in my analyses.
uORFs within 5' UTRs from genes that have at least one uORF that does not overlap an 
exon and have an upstream coding region (set g, Supplemental Figure S4.1) were 
interrogated for evidence of translation by analysis of RPFs using the tool ribORF (Ji et 
al. 2015). ribORF was given as input the specified ORFs with RPFs from in silico 
combined 5 male and 5 female liver RPF samples, as well as a set of all 10 RPF samples 
(male and female reads combined) to identify uORFs that are apparently translated for 
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each of the read sets: male, female, and sex-combined. ribORF utilizes the 3 nt 
periodicity of ribosome-protected fragments, as well as overall “uniformity” of reads 
across the ORF in question, to predict uORFs that are engaged in active translation (Ji et 
al. 2015). These uORFs were interrogated by ribORF for the 3 read sets. Each uORF was 
designated as coding or not coding based on the p-value (here referred to as “prediction 
value”) returned by ribORF. The default prediction value cutoff of > 0.7) was used to 
designate coding sequences. 
4.3.10 Differences in TE for gene sets having different uORF status
TE was interrogated for genes having specific sets of uORF status. TE for genes having 
no uORF (set f, Supplemental Figure S4.1) were compared to those of genes with at least 
one uORF (set g, Supplemental Figure S4.1). Similar TE comparisons were made for 
genes having coding uORF status vs. not coding (sets j + l for coding, sets k + n for non-
coding). TE of genes having coding uORFs with and without 3' partial status (sets j and l,
respectively),were compared to genes with non-coding uORFs. These comparisons 
showed how TE was modulated specifically by uORFs having near vs. distant proximity 
to the translation start site, where nearby coding uORFs were postulated to have a greater 
effect on TE. Further, TE values for genes with a uORF were compared to those of a set 
of genes without a uORF, after filtering for genes with comparable cellular localization, 
indicated by N to C values. For each gene with a uORF, a gene having the closest TE 
value in the set of genes without a uORF was selected. This yielded a set of genes with a 
uORF and a set of genes without a uORF having comparable N to C ratios. The 
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distribution of TE values for these two gene sets were then visualized and compared 
using a t-test. These gene sets were interrogated using an “expressed” cutoff of requiring 
all genes to have whole cell transcript abundance of TPM > 1, or in some cases using a 
more “stringent” cutoff of TPM > 2.
4.3.11 Effect of cellular localization on TE
In a separate set of wet lab experiments conducted by Dr. Pengying Hao of this 
laboratory, RNA-seq libraries were prepared from mouse liver nuclei (nuclear RNA-seq) 
or from mouse liver cytoplasm (cytoplasmic RNA-seq) isolated from n=2 male and n=2 
female adult mouse livers. Cytoplasmic and nuclear RNA was extracted and sequenced 
from these livers using methods described in Dr. Hao’s PhD Dissertation (Section 5.E 
Methods). These RNA-seq datasets are available at GEO accession GSE119614. TPM 
values were calculated for each gene, as defined by the “exon no UTR” GTF file, and 
bias for cellular localization was defined as the N to C ratio. In order to avoid division by 
zero, for the cytoplasmic library a pseudocount (lowest TE value for cytoplasmic library, 
male or female, ~ 0.0104) was added to all genes. Genes having a very low TE value (TE
< -5, corresponding to log2(-5) = 3.1% efficiency of translation) were shown to have a 
bias for nuclear localization, as determined by gene set enrichment analysis (GSEA) 
using the fgsea R package (Sergushichev 2016). GSEA was run on genes with low TE 
defined as TE < -5, as well as high TE, corresponding to TE > 2.2, separately for male 
and female livers. To calculate this enrichment, GSEA was given as input: 1) a list of 
genes ranked by N to C ratio, and 2) a set of genes with low TE in the set of sex-specific 
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genes, with data for male and female livers analyzed separately. Further, all genes 
included in this ranked set had a minimum TPM > 1 for either nuclear or cytoplasmic 
compartments after adding the pseudocount to the cytoplasmic TPM values as described 
above. N to C ratios were compared for gene sets interrogated for TE differences in order
to establish the potential bias of TE values for transcripts with different subcellular 
localizations.
4.3.12 Transformation of RPF values to normalize TE values
The TE values of all 10 samples were transformed according to a model generated using 
a set of “reliable” genes in order to calculate a range of TE values with a mean RPF to 
RNA-seq TPM value set as zero as outlined in Ingolia et al. (Ingolia 2009). To obtain a 
set of reliable genes, average TPM values for male and female livers separately were 
used together with average TE values to apply cutoffs (filters) as described here and in 
Supplementary Figure S4.2 A. The set of reliable genes was required to have finite TE 
values for all samples (finite TE for all 5 male and all 5 female liver samples), a male to 
female TE difference between 1.25 and 0.8, and the TPM in the whole liver RNA-seq 
must be > 1 in either male or female livers. This yielded a filtered gene set of 8,240 genes
that captured ~94% of all reads mapping to the original set of 24,197 RefSeq genes prior 
to filtering. From this set of reliable genes, using average TPM calculated from all 10 
male and female livers, a linear model was built. This model was generated in log2 space 
to improve robustness due to the wide scale of TPM values (Supplementary Figure S4.2 
B). This model generated from the reliable gene set yielded a slope and y-intercept. The 
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TPM values for the RPF datasets were transformed so that the transformed slope was 1 
and y-intercept set at 0 according to Supplementary Figure S4.2 C. In this way, the 
average RPF vs RNA-seq values was set to ~ 1 as the model was built to make x=y 
(transformed data slope=1 Supplementary Figure S4.2B). The data was normalized so 
that normalized TE values would span from 0, where 0 represented the median TE value, 
and genes having TE values greater than 0 have, in general, higher relative efficiency in 
translation, and negative values represented correspondingly less relative translational 
efficiency. For the set of “reliable” genes, the average RPF and RNA-seq TPM values 
before and after the transformation are given in Supplementary Table S4.4. The actual 
value for average RPF transformed vs RNA-seq TPM values for the filtered dataset was 
1.1626 after the transformation, and the median was 1.0679 (Figure S4.2 D). Further, the 
distribution of TE values of the “reliable” gene set before and after the transformation is 
shown in Supplemental Figure S4.2 D. The same transformation generated from the 
model using the reliable genes was then applied to all 10 RPF livers, and this transformed
dataset was used in every calculation for TE. The average and median RPF / RNA-seq 
ratios for each individual liver are outlined in Supplementary Table S4.5
4.3.13 ribORF analysis of lncRNA sequences: Prediction of translation within ORFs
of lncRNAs
From a set of 15,558 lncRNAs discovered by Dr. Melia of this lab, TransDecoder was 
used to detect open reading frames within all isoforms of all lncRNAs using the 
parameters described above for 5’ UTRs. These ORFs were interrogated using RPFs 
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from sex combined male and female livers, as well as a set of RPFs from all livers 
(combined 10 RPF samples, 5 male and 5 female). Each of these read sets yielded 
ribORF results outlined in Supplemental Figure S4.LNCRNA. We used these ribORF 
results to identify ORFs as coding as follows: Any ORF must have a prediction value of 
> 0.7 and a minimum read count was set at 10, with a further requirement that each ORF 
must have a read count to ORF length ratio of > 0.1. A total of 938 translated peptides, 
derived from 397 of the 15,558 lncRNA genes, were thus identified. The TransDecoder 
annotation with the ribORF results for each of the 3 read sets male combined, female 
combined, and all 10 RPF read sets are given in Supplementary Table S4.LNCRNA
4.4 Results
4.4.1 Characterization of the mouse liver transcriptome and translatome
Illumina sequencing libraries were prepared for whole liver RNA-seq and Ribo-seq 
analysis of male and female mouse liver (n=5 livers per sex). Libraries were prepared and
sequenced by Dr. Pengying Hao of this laboratory (Materials and Methods). These 
datasets were comprised of matched whole liver RNA-seq and corresponding RPF 
datasets (Figure 4.2A). A 3 nt periodicity was seen in the RPF reads mapped to protein 
coding genes, as is expected for fragments that are truly protected by ribosomes engaged 
in protein translation. This is seen in Figure 4.3 (top two plots), where the per nucleotide 
resolution signal of RPFs is plotted vs. their position relative to the translation start and 
stop sites of all RefSeq-annotated protein coding genes. As expected, no 3 nt periodicity 
was observed for sequence reads from the whole liver RNA-seq dataset (Figure 4.3, 
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bottom two plots). 
4.4.2 Translational efficiency of liver-expressed genes
The whole liver RNA-seq signal represents transcript abundance within the cell, while 
the Ribo-seq signal indicates the extent of RNA translation. These two data sets were 
used to determine TE values, which were calculated as log2 of the ratio of TPM for RPF 
vs. whole liver RNA-seq signal where the RPF TPM values were transformed so that the 
median TE was 0, such that positive TE values indicate higher TE and negative TE 
values indicate lower TE than that of the median TE for a liver-expressed gene (Materials
and Methods). These data were visualized for protein coding genes in male and female 
liver in Figure 4.4 for all genes that have a minimum DF of 3, i.e., 3 finite TE values. For 
each gene, the average log2 of the TPM for RPF (y axis) is graphed vs the average log2 
of the TPM for whole liver RNA-seq reads (x axis), with a green line showing a best fit 
model generated from the average log values. For males and females, the slope of this 
line is ~0.98, i.e., the transformed RPF vs whole liver RNA-seq TPM values are close to 
1. The average actual ratios for these values are given in the figure (for males, average 
RPF/RNA-seq ratio = 1.3829, median 1.1205, and corresponding female average 1.3706 
and median 1.1222). Genes expressed in liver at TPM < 1 were included in the figure to 
determine the characteristics of lowly expressed genes, as discussed below. In both male 
and female livers, the distribution of TE values for lowly expressed genes was much 
greater than for highly expressed genes, suggesting they may be subject to greater 
translational regulation than highly expressed genes. To illustrate the relationship 
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between TE and whole liver transcript abundance, the average TEs for male and female 
livers were plotted against corresponding whole liver TPM values for all genes with DF ≥
3 (Figure 4.5). These figures reveal a positive correlation for TE vs. whole liver 
transcripts (slope of best fit curve ~0.18-0.19 for male and female livers).
The distribution of TE values for all individual male and female livers is presented in 
Figure 4.6. The majority of TE values ranged from -5 and 5 (+/- RPF/RNA-seq = log2(-5)
= 3.1% efficiency). A low apparent translation rate could reflect either low intrinsic 
translational efficiency, or alternatively, extensive localization of an RNA in the nucleus, 
where the RNA transcripts would not be available for ribosomal engagement, and would 
thus be depleted from the Ribo-seq dataset. To ascertain whether differences in cellular 
localization, rather than low efficiency of translation, explain low TE values, RNA-seq 
libraries were prepared from a separate set of male and female livers whose nuclear and 
cytoplasmic RNA fractions were sequenced. These RNA-seq data were analyzed to 
determine an N to C ratio for each gene (log2 of [nuclear TPM / cytoplasmic TPM]). 
Genes with TE < -5 (~90 genes for male and female liver) showed significant enrichment
for nuclear localization, as indicated by GSEA analysis compared to a ranking of genes 
by decreasing N to C ratio (Figure 4.7). This finding strongly suggests that a large 
fraction of genes with low TE values is due to nuclear localization of the RNA. However,
a few individual genes in the low TE gene sets showed average N to C ratios; these 
correspond to cytoplasmic transcripts with bona fide low TE values. Further, many genes 
with low TE showed very low transcript abundance (Figure 4.5). Additionally, genes 
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having TE > 2.2 (~90 genes in male / female liver) have high enrichment for cytoplasmic 
localization. Genes having the highest TE values were enriched for cytoplasmic 
localization, as expected for otherwise they would not be available for ribosome binding 
in the nucleus and would be inefficiently translated. Supplemental Table S4.NC_ratio 
shows N to C values, and the underlying RNA-seq values, used to calculate these ratios 
for all 24,197 RefSeq annotated genes.
4.4.3 Sex Differences in TE
For each gene, TE was calculated for male and female livers separately, and the sex 
difference in TE was then calculated as: Sex Δ TE = (TE in male liver) – (TE in female 
liver). The sex Δ TE for each gene is visualized, along with the corresponding average 
transcript abundance determined by whole liver RNA-seq, in Figure 4.8. The highest sex 
differences in TE were observed for those genes having low whole liver transcript 
abundance. Only genes having TPM > 1 for average male / female were included in 
downstream analysis (average TPM > 1, right of vertical green line). Additionally, a 
cutoff of sex Δ TE=1, i.e., > 2-fold difference in TE between male and female liver, was 
applied to decrease the likelihood of false positives. Thus, genes showing significant sex 
differences in TE are shown above the upper red line (greater TE in male livers) and 
below the bottom red line (greater TE in female livers). Overall, 213 genes met both sex 
Δ TE and minimum average TPM cutoffs (Supplemental Table S4.2). 
For each of the 213 genes, a t-test determined the significance of sex Δ TE. This t-test 
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interrogated TE values from individual livers having a minimum number of calculable 
TE values for significance in difference (DF ≥ 3, Materials and Methods). P-values 
representing the significance of sex Δ TE were obtained for each male vs female 
comparison. 51 of the 213 genes showed significant sex Δ TE at P < 0.05 when analyzed 
individually. However, after correction for multiple hypothesis testing using a false 
discovery rate method (Benjamini Hochberg, BH), none of the 284 genes showed a 
significant sex Δ TE, even at a relaxed FDR of P < 0.1. For all 213 genes within the 
specified cutoffs, the gene with the smallest adjusted p-vaule had an adjusted p-value of 
~0.08 (Rnf170).
4.4.4 Translational efficiency of sex-specific genes
TE values for sex-specific genes (201 male-specific and 239 female-specific genes, 
Supplementary Table S4.SEX_SPEC_GENES) were compared to those of a set of 
stringently selected sex-independent genes across the sets of male and female livers. As 
RNAs that preferentially localize to the nucleus show lower TE than cytoplasmic RNAs 
(Figure 4.7), I further filtered the set of stringently sex-independent genes to select a gene
set that matches the sex-specific genes with regard to nuclear vs cytoplasmic localization 
(N to C ratio; see Materials and Methods). Figure 4.9 presents boxplots showing the 
distributions of TE values for sex-specific genes (red) in both male and female liver, 
binned based on their whole liver RNA-seq TPM values, and compared to TE values for 
a comparably expressed and comparably localized set of stringently sex-independent 
genes (blue). These results are summarized in Supplemental Figure S4.3. In general, sex-
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specific genes showed very similar or slightly higher TE when directly compared to 
similarly expressed and comparably localized sex-independent genes, however any 
differences were not significant based on a t-test with correction for multiple hypothesis 
testing (BH). Thus, sex-specific mRNA transcripts are translated at levels comparable to 
similarly transcribed / localized sex-independent liver expressed genes. This, together 
with the absence of major, significant sex differences in TE, indicates that sex difference 
in expression determined by whole liver RNA-seq are very likely to be maintained at the 
protein level. N to C values for these genes are plotted in Figure 4.9 (right column of 
plots), which confirms our selection of sex-independent genes with comparable N to C 
ratios for each bin.
4.4.5 Characterization of untranslated regions: uORFs within 5' UTRs
Genes having one or more uORFs may show a decrease in TE compared to genes having 
no uORF by a mechanism that involves ribosomal interference (Sendoel et al. 2017; 
Couso & Patraquim 2017; Calvo et al. 2009). Figure 4.10 presents a model based on 
these studies that involves stalling of scanning ribosomes by creating a ribosomal 
roadblock as these ribosomes traverse the RNA, moving towards the translation start site.
To investigate this model for modulation of TE by translation of uORFs, 5’ UTRs within 
the mouse genome (mm9) was scanned for uORFs using TransDecoder (Haas et al. 
2014). The uORFs identified were partitioned into two groups based on their location 
within the 5' UTR. Complete uORFs are those that have start and stop codons completely
within the 5' UTR; uORFs that start within the 5' UTR and continue into the gene body 
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are designated partial ORFs, as they are cut off at the 3’ end (3’ partial). (Figure 4.10). 
The distribution of the number of uORFs per gene is shown in Figure 4.11. These uORFs 
were interrogated by ribORF, which uses the 3 nt periodicity of the RPF signal and the 
overall uniformity of coverage across putative coding regions to predict the likely protein
coding status of each uORF based on a statistical test (see Methods, Supplementary Table
S4.3 for ribORF results of uORFs). I then compared the TE for the set of genes with any 
uORF determined by the scan carried out by TransDecoder vs without genes uORFs 
(Materials and Methods), and for genes with uORFs determined to have translating 
ribosomes bound by ribORF vs uORFs that were similarly determined to not have 
ribosomes bound. Separately, I compared TE values for genes with complete vs. partial 
uORFs to determine the impact of uORF translation start site proximity on TE.
11,015 liver-expressed protein coding genes have 5' UTRs based on their RefSeq 
annotation, and 3,793 (~34%) of these 5' UTRs have one or more uORFs yielded by the 
TransDecoder scan that were of the minimum specified length (9 codons, 27 nts) that do 
not overlap with an exon, and have a translation start site according to RefSeq annotation 
(Materials and Methods). Figure 4.11 shows that a large majority of genes with 5' UTRs 
have between 1 and 8 uORFs, with a small number of genes having between 8 and a 
maximum of ~32 uORFs. To investigate how uORFs affect TE, TE values of genes with 
whole cell transcript abundance TPM > 2 (“stringent” set, Materials and Methods) having
at least one uORF were compared to those genes without uORFs. Figure 4.12A, left, 
presents the difference in distribution of TE values for genes with vs. without uORFs, 
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which is striking, with p = 6.9 x 10126 (t-test) and a median TE difference of 0.542. This 
difference was still significant after filtering the set of genes without uORFs to include 
only genes having comparable cellular localization to that of corresponding genes with 
uORFs, as determined by N to C ratio (p=1.16x1074, median TE difference 0.446; Figure 
4.12A, right). Thus, genes with uORFs show lower TE values, and these lower TE values
cannot be explained by differences in cellular localization.
To further investigate the model proposed in Figure 4.10, we compared the distributions 
of TE values for several gene subsets using the “stringent” cutoff and found to have a 
uORF by TransDecoder and predicted by ribORF analysis to have translating ribosomes 
(Prediction value > 0.7 for the uORF region, but without a minimum read count) (marked
in red), which have potential for ribosomal interference with translation initiation, to gene
sets with uORFs having no evidence of active translation, as predicted by ribORF 
(marked in blue) (Figure 4.12 B-D). The TE for the protein coding sequence of genes 
having ≥ 1 ribORF-predicted uORF, and with RibORF evidence for translating ribosomes
in the uORF region, was significantly less than those uORFs having no evidence of 
coding (Figure 4.12 B; p=8.06x10-8, median difference in TE=0.25). This supports the 
model that translated uORFs have the ability to decrease TE, and that ribosomes bound to
uORFs may indeed interfere with translation initiation. Next, I examined whether 
proximity to the translation start site influences the degree to which a uORF may 
decrease TE. TE values of genes with uORFs showing evidence for the presence of 
translating ribosomes that have either complete or partial status were determined and then
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compared to those of non-coding uORFs. In both cases, the difference in TE was 
significant (p=3.83x10-5 for complete coding uORFs, p= 3.37x10-6 for partial; Figure 4.12
C-D). Strikingly, the median difference in TE for complete coding uORFs (0.20) was less
than that of partial coding uORFs (0.33). The proximity of interfering ribosomes to the 
translation start site may therefore play a role in the modulation of TE by ribosomal 
interference. This supports the model for ribosomal interference of translation initiation 
via elongation of uORFs within the 5' UTR of genes, as these partial coding uORFs are 
more likely to physically interact with initiating ribosomes at the translation start site. A 
detailed listing of average difference in TE, and significance of difference determined by 
t-test for TE values of the specified uORFs, is presented in Supplemental Figure S4.6 for 
both “stringent” and “expressed” gene sets. Further, corresponding differences in TE 
distributions for the same gene sets using the “expressed” cutoff are shown in 
Supplementary Figure S4.4. 
Given our finding that cellular localization of transcripts can bias TE, all gene sets 
interrogated for TE differences in Figure 4.12 were also examined for cellular 
localization differences. Figure 4.13 shows histograms of N to C ratio values for the gene
sets corresponding to those evaluated in Figure 4.13. Only the gene sets with vs without 
uORFs show any significant difference in N to C ratio (Figure 4.13A; N to C ratio 
difference 0.48, p=3.95x10-46), with genes having uORFs being more nuclear localized 
compared to those genes without uORFs. While the mechanism underling this finding is 
not clear, cellular localization is able to account for much of the observed TE difference 
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as N to C values for genes with uORFs vs without is highly significant (Figure 4.13A, 
median N to C ratio difference 0.48, p=3.9 x1046). N to C ratios for genes with different 
TE values outlined in Figure 4.12B-D do not have significant differences in N to C ratios,
indicating that these TE differences are bona fide, and are not an artefact of cellular 
localization. N to C values for genes having less stringent cutoff of minimum TPM > 1, 
or the “expressed” set within Supplemental Figure S4.4 are shown in Supplemental 
Figure S4.5, and median TE, NC, and corresponding p-values for both the less stringent 
“expressed” dataset with the stringent dataset are presented in Supplemental Figure S4.6. 
4.4.6  ORFs in liver-expressed lncRNAs – A set of 15,558 mouse liver expressed 
lncRNAs defined by Dr. Tisha Mela of this laboratory was interrogated for translation 
using the RPF datasets.  First, each isoform of each lncRNA was analyzed to determine 
the presence of an open reading frame(s) using TransDecoder.  Using this annotation, 
together with the combined set of reads processed as per ribORF guidelines (Materials 
and Methods), lncRNAs were flagged as having evidence for translation within an ORF.  
In all, 938 unique ORFs were found to have evidence of translation within 397 lncRNAs, 
based on the following threshold criteria for a translated uORF: reads per ORF nt length 
> 0.1, ribORF prediction value of > 0.7, and Ribo-seq read count > 10.  These 397 
lncRNAs thus show evidence for translation of 922 peptides. Further work will be needed
to identify the functions of these predicted peptides and any possible sex differences in 
their expressed peptide levels. 
4.5 Discussion
119
The transcriptional landscape of male and female livers is well described regarding sex 
differences in mRNA transcript abundance. Mechanisms for the observed transcriptional 
differences include activation of the JAK-STAT pathway by growth hormone (Clodfelter 
et al. 2006; Yang et al. 2006; Lau-Corona et al. 2017). These and other mechanisms 
explaining sex-differential transcript abundances advanced our understanding of 
maintenance of sex differences in mouse liver (Laz et al. 2009; Ling et al. 2010; Meyer et
al. 2009; Conforto et al. 2015). While these studies focused on sex differences in the 
mouse liver transcriptome, the effect of the translation step, which presents many 
opportunities for post-transcriptional regulation (Hershey et al. 2012), has yet to be 
determined. Here, I used Ribo-seq together with whole liver RNA-seq to determine 
translational efficiency (TE) values for all genes. I investigated the role that TE may play 
in post-transcriptional regulation in male and female mouse liver. TE was calculated 
using liver Ribo-seq libraries together with matched whole liver RNA-seq libraries. 
Differences in intracellular localization were found to bias TE. I found that sex 
differences in TE were not significant for liver-expressed transcripts. The impact of the 
presence of an uORF on translational regulation, as previously proposed (Morris, David 
R, Geballe 2000, Johnstone, Bazzini, and Giraldez 2016), was also examined. Further, 
TE distributions for genes with different uORF status were investigated for three main 
components of the model presented in Figure 4.11. 
Ribo-seq together with RNA-seq have previously been used to calculate TE values 
genome-wide (Ingolia et al. 2009; Ingolia 2014). As Ribo-seq captures transcripts 
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engaged with the ribosome, transcripts quantified by Ribo-seq are expected to be 
localized to the cytoplasm. RNAs that are primarily localized to the nucleus are expected 
to be largely unavailable for ribosome binding, and hence will have low TE values. 
Indeed, in Figure 4.7, I observed that RNAs with low TE (TE < -5) were highly enriched 
for nuclear localization. This issue was not specifically addressed by Janich et al. (Janich 
et al. 2015), who used whole mouse liver for RNA-seq datasets to calculate TE values, 
and found a small number of genes with TE < -5. Our findings indicate that these 
extremely low TE values could be an artifact of cellular localization, as shown in Figure 
4.7. Additionally, Janich et al. showed that in mouse liver, TEs of dynamic (rhythmic) 
transcripts had significantly higher TE values than the global population of transcripts. 
My work showed less striking difference in TE between dynamic sex-specific genes that 
are dynamic in the sense that they are under sex-specific pressures to increase 
transcription, compared to the global population of stringent sex-independent genes not 
under this pressure and having comparable N to C ratios (Figure 4.10). This N to C ratio 
may in part explain the TE difference between dynamic and global genes presented by 
Janich et al. Application of a genome-wide correction for RNA localization, by applying 
the N to C ratio to adjust whole liver RNA-seq read counts, could complicate the use of 
read counting tools requiring discreet read counts. (FeatureCounts, for example, cannot 
accept a fraction of a read) In place of this global correction, gene sets interrogated for 
TE differences were either only compared to genes having similar cellular localization 
(Figure 4.10; Figure 4.13A, right histogram) or N to C values were compared together 
with TE (Figure 4.13 TE comparisons with corresponding N to C values shown in Figure 
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4.14). If N to C values were significantly different, any difference in TE could be 
explained by the previously discussed cellular localization artifact.
Genes were interrogated for genome-wide sex Δ TE. In a previous study, male and 
female gonadectomized mouse livers were interrogated to determine mRNA abundance 
and enzyme activity (a surrogate for protein levels) for type I iodothy-ronine deiodinase 
(Dio1) (Riese et al. 2006). The results obtained raised the possibility that a sex difference 
in TE characterizes Dio1 RNA in mouse liver, and differences in TE for Dior may occur 
between liver and kidney. Post-transcriptional regulation of genes by TE is well 
established in other systems (Dai et al. 2017; Gerashchenko et al. 2012), in which 
specific perturbations were identified that cause distinct, quantifiable shifts in TE for sets 
of genes. These observations show that sex differences in TE may exist for mouse liver or
between tissues. However, on a genome-wide scale, sex Δ TE was not observed in my 
analyses.
A model for TE modulation by uORFs within 5' UTRs of genes was examined by 
interrogating RPFs from our Ribo-seq dataset for their effect on TE in several contexts. 
First, genes with uORFs and without uORFs were found to have strikingly different TE. 
However, upon interrogating the same gene sets for N to C ratios, I found N to C could 
explain a portion of this difference (Figure 4.14A). For studies such as this, and a study 
demonstrating enzyme activity differences in genes with vs. without uORFs (Calvo, 
Pagliarini, and Mootha 2009), where this issue wasn't specifically addressed, N to C 
122
ratios of genes should be taken into account when estimating TE values. For the 
subsequent TE comparisons for different sets of uORFs outlined in Figure 4.13, the 
possible bias of TE values due to localization is not significant, and differences in TE 
values do not simply reflect differences in cellular localization.
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Figure 4.1 Ribo-seq assay overview. Where engaged with the mRNA, ribosomes 
locally “protect” mRNA sequences from digestion by ribonuclease treatment. Ribosome 
protected fragment (RPF) sequence reads from these protected regions represent genome-
wide locations of engaged ribosomes at a per nucleotide resolution. RPFs were mapped 
back to the genome, and ORFs within protein coding gene bodies and uORFs within 5' 
UTRs were interrogated for RPF reads. In general, signal from RPFs within ORFs 
(specifically, annotated coding genes illustrated in Figure 4.3) showed evidence of active 
translation of peptides. These reads were adjusted so that the 5' start of each read was 
within the active site of the ribosome and not the edge of the ribosome which protected 
the mRNA, following the guidelines of the ribORF tool (Materials and Methods).
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Figure 4.2 Experimental design. 
(A). Male and female mouse livers, RPF and RNA-seq. Libraries from male (blue) and 
female (yellow) livers were prepared and analyzed by RPF and whole liver RNA-seq 
assays (Materials and Methods). Samples S1-S5 represented matched set of livers 
separately for male and female; libraries from single liver samples were sequenced using 
both assays and have matching RPF and RNA-seq read sets. This matched set of 5 livers 
for males and females represented the basis for all translational efficiencies (TE) 
calculations described in (B) and sex Δ TE (C). 
(B). TE calculation for 5 matched liver samples. TE was calculated for all genes using 
the paired libraries of each matched liver set. Specifically, TE was calculated as the log2 
ratio of RPF vs RNA-seq TPM, which represents a normalized signal intensity from each 
assy. This TE is therefore the “efficiency” at which each mRNA transcript is translated 
(Materials and Methods). A TE was calculated for each paired liver set, which yielded a 
maximum of 5 TEs separately in male and female livers for each gene. The number of 
finite TE values, or degrees of freedom (DF) for a given gene represents the number of 
livers that have a calculable TE, or all genes with RNA-seq signal of > 0 (Materials and 
Methods). 
(C). Sex-differential TE calculation. TE values from 5 male and 5 female livers were 
averaged, yielding a set of TE values for all genes with DF ≥ 3. For each gene, the 
difference of these averages is represented as the sex Δ TE. A difference was taken to 
represent this sex difference in TE, because TE was the log ratio of RPF/RNA-seq, as 
shown in (B). 
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Figure 4.3 Aggregate RPF signal anchored at translation start sites of coding 
genes. For male liver A2 (G148 M2 RPF sample and G124-125 M34 whole liver RNA-
seq) aggregate, nucleotide resolution, signal from RPF libraries (top) and whole liver 
RNA-seq libraries (bottom) are plotted anchored at RefSeq genes. Top plots, RPF signal 
normalized by reads per million (RPM) from a male liver samples. Bottom plots, whole 
liver RNA-seq RPM normalized signal from corresponding whole liver RNA-seq reads 
form the same liver. Right and left plots anchor these reads at RefSeq-annotated start and 
stop codons, respectively. For all plots, 5' ends of reads adjusted according to ribORF 
guidelines, are plotted at a per nucleotide resolution.
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Figure 4.4 Translatome vs. transcriptome: RPF vs whole liver RNA-seq signal. 
Signal from RPF vs RNA-seq TPM signal from male and female livers was plotted for all
24,197 genes using the custom “exon no UTR” annotation (Materials and Methods). 
TPM was calculated using combined 5 RPF and 5 whole liver RNA-seq libraries 
separately for male and female livers. For these plots, the log2 TPM for RPF reads were 
plotted against the log2 TPM for whole liver RNA-seq reads with a model generated 
from the log2 RPF and RNA-seq signal marked with a dashed green line. The average 
and median values for the RPF vs RNA-seq TPM values are given separately for male 
and female livers.
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Figure 4.5 TE values vs. log2 TPM whole liver transcript abundance for male 
and female livers. Shown here is the relationship of TE and abundance of mRNA 
within the cell. Shown are all genes having >=3 finite TE values (DF, degrees of 
freedom) in order to illustrate that less abundant transcripts are less efficiently translated.
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Figure 4.6 Distribution of average TE values for male and female livers. Ribo-seq
and whole-liver RNA-seq sequence reads from 5 male and 5 female livers were used to 
calculate TE values (Materials and Methods). Shown are histograms displaying 
distributions of TE values for individual male and female livers for genes whose whole 
liver RNA-seq and Ribo-seq TPM was > 1 and had a minimum finite TE values (DF) ≥ 3.
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Figure 4.7  Gene set enrichment analysis (GSEA) of genes having low and high 
translational efficiencies . Reads from 5 male and 5 female livers from the whole liver 
RNA-seq and Ribo-seq libraries were used to calculate TE. Gene sets with TE < -5 (90 
male, 97 female) were interrogated for enrichment of cellular localization. Cellular 
localization was determined from nuclear to cytoplasmic ratio calculations using a 
separate set of nuclear and cytoplasmic libraries prepared from 2 male and 2 female livers
(Materials and Methods). All 12,184 genes in male livers and 12,443 genes in female 
livers having TPM > 1 for nuclear or cytoplasmic TPM were ranked by N to C ratio 
(highly nuclear to highly cytoplasmic). GSEA revealed that genes having low TE (TE < -
5) are enriched for nuclear localization, for male and female livers. For genes with high 
TE (TE > 2.2), transcripts were biased for cytoplasmic localization as translated genes do 
not undergo elongation in the nucleus. 
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Figure 4.8 Sex Δ TE vs. average abundance of total liver mRNA. Sex Δ TE vs 
average transcript abundance was plotted for genes meeting DF cutoff ≥ 3 in both male 
and female livers (Supplementary Table S4.1, includes all 24,197 genes). For this plot, 
sex Δ TE (Materials and Methods) vs average whole cell transcript abundance was 
plotted for each gene. The sex difference in TE was plotted on the Y axis. Plotted on the 
X axis are corresponding average transcript abundance values based on the combined 
male and female read sets (TPM) for each gene. Each dot in the plot therefore represents 
the average sex Δ TE and an average abundance of mRNA within male and female livers.
Here, sex Δ TE genes are defined as having at least a 2x TE difference between male and 
female livers (above top red line, below bottom red line, 629 genes).
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Figure 4.9 Sex-specific TE vs. average sex-independent TE within male and 
female livers. Sex-specific genes were binned by mRNA abundance, and TE values for 
sex-specific genes were to those of stringent sex-independent genes having comparable 
transcript abundance and N to C ratio for each bin (Materials and Methods). Boxplots on 
the left, distributions of TE values for sex-specific (red) and the specified sex-
independent (teal) gene sets, separately for male and female livers (top, bottom). N to C 
ratio values are similarly plotted to the right for males and females. Box plots on the 
right, distributions of N to C ratio values for genes interrogated for TE.
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Figure 4.10 Model for modulation of translational efficiency by uORF translation.
A model showing molecular mechanisms by which interference from ribosomes within 
the uORF block translation initiation at the TSS. The 5' UTR (gray box) of a gene is 
shown upstream of a positive-strand coding transcript (first exon, blue box with start 
codon “AUG,” green box). Shown are two distinct uORF types (uORF status): complete 
and 3'-partial. Complete uORFs are located completely within the UTR; they began with 
the start codon AUG and end with the stop codon TGA, without overlapping the 
translation start site of the first exon. 3'-partial status uORFs begin with the same 
upstream start codon, and continues through the translation start site. However, for this 
annotation, the uORF position ends before the start codon of the first exon of the 
transcript. 
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Figure 4.11 Distribution of uORFs for liver-expressed genes with 5' UTRs. For all 
plots in this figure, histograms show distributions of uORF counts found within the 5' 
UTR regions of the mouse genome. A Histogram showed the distribution of number of 
specified uORFs (y axis) binned by log2 number of uORFs (x axis). For this histogram, 
the first bin between log2(uORFs)=0 and log2(uORFs)=1 represented genes having 
#uORFs = 1, and the second bin between log2(uORFs)=1 and log2(uORFs)=2 show 2 <=
#uORFs < 4, etc. 
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Figure 4.12 Distribution of TE, genes with uORF, coding uORF, stringent set
For each figure, TE values calculated from male / female combined reads from Ribo-seq 
and whole liver RNA-seq libraries were used to calculate TE values. Histograms of TE 
distribution for each of the specified gene sets defined by corresponding diagrams (right) 
are shown. Each plot illustrates the difference in TE for the two gene sets. The values on 
the X axis were average TE values calculated from the sex combined read set, with 
corresponding relative TE frequencies on the Y axis. The median difference of TE was 
calculated as the average difference in TE for all genes within the specified gene sets. 
This mean difference is shown together with a corresponding p-value (t-test). Each of 
these histograms made a comparison interrogating a specific component of the model for 
modulation of TE by uORFs presented in the text and Figure 4.11 where, according to the
model, red gene sets are postulated to show a diminished TE compared to that of the blue 
set. The TEs visualized in Figure 4.13A-D were all determined using sex-combined RPF 
and whole liver RNA-seq read sets, with a stringent value of TPM > 2 used to designate 
liver-expressed genes. Standard expressed gene results are shown in Supplemental Figure
S4.4. 
(A). Left histogram. Distributions of TE for liver expressed genes with a 5' UTR 
partitioned by with (red) / without uORF (blue) status.
(A) Right histogram. This histogram shows the distribution of TE values for genes with 
uORFs (red) compared to that of genes having similar N to C ratios (blue, Materials and 
Methods). 
(B). Distributions of TE for 3,793 genes having at least one uORF, partitioned by coding 
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(coding) or not coding (blue)
(C). TE distributions for 3,054 genes partitioned by coding having no 3'-partial uORF 
status (red) / genes with non-coding uORFs (blue).
D). TE distributions for 2,580 genes, those having at least one coding uORF with 3' 
partial status (red) / uORFs without coding status (blue)
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Figure 4.13. Corresponding N to C ratios for gene sets outlined in Figure 4.13. 
From Figure 4.13, TE distributions are compared for specified genes with uORF status. 
Here, as cellular localization of genes determined by N to C ratio, distributions of this N 
to C ratio are plotted for the same genes partitioned by the specified uORF status.
A) N to C ratio for corresponding plot in Figure 4.3A; B) N to C ratio for corresponding 
plot in Figure 4.3B; C) N to C ratio for corresponding plot in Figure 4.3C; D) N to C ratio
for corresponding plot in Figure 4.3D
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Supplemental Figure S4.1: Discreet gene sets used in 5' UTR, uORF analysis. Liver 
expressed genes for this study were further sub-divided into discreet gene sets. For each 
gene set a-m, genes were divided by expressed / not expressed in liver, with / without 
UTRs or uORFs, etc so that all genes from the master list of 24,197 genes were 
accounted for. Genes within Figure 4.12 were specifically chosen from these sets. For 
example, the set of genes with coding uORFs were genes within sets j and l, etc.
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Supplemental Fig S4.2 Transformation of the RPF TPM values. Ingolia et al 
(Ingolia 2009) showed how transforming the RPF dataset so that the ratio of RPF to 
RNA-seq TPM values to 1 can be used to normalize the data. A. Process for selecting a 
set of reliable genes to be used in the normalization. These genes were used to generate 
the model and were a good representation of robust genes within the RPF and RNA-seq 
datasets. B. Model generation and transformation based on the reliable gene set from A. 
A linear model was generated for the reliable gene set using the log averages of the RPF 
and RNA-seq datasets as described (see Materials and Methods). This model was then 
used to transform TPM values of the RPF datasets within the reliable gene set, so that a 
linear model for the transformed dataset had a slope of 1 and a y-intercept of 0. C. 
Equation for transforming the TPM values of the RPF datasets. D. Distribution of RPF vs
RNA-seq ratio before and after the transformation. Additionally, average and median 
ratios are given.
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Supplemental Figure S4.3 Number of male and female sex-specific and 
approximate sex-independent TE values, with p-values for difference in TE and N to
C ratio. For the boxplots presented in Figure 4.9, significance of TE difference is 
calculated using a t-test for sets of sex-specific genes against a set of average TEs from 
stringent sex-specific genes that have similar localization and transcript abundance 
determined by whole-cell RNA-seq (Materials and Methods).  Here, the number of genes 
in each bin for sex-specific genes are presented. Additionally, the number of 
corresponding TE approximation form a set of genes that approximate localization and 
abundance are given.  The significance of difference in TE for the sex-specific gene set 
and the average of TE values of sex-independent genes are given as p-values for each bin 
(P-value:TE and for corrected pvalue: Adj. P-value:TE, FDR adjusted using Benjamini-
Hotchberg method). Additionally, for the corresponding N to C ratio comparison, 
corresponding significance in difference of this ratio are given (p-value and adjusted p-
value as done for TE).
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Supplemental Fig S4.4: Differences in TE distribution, expressed gene set. 
Differences in TE for genes with a lower TE minimum for whole cell RNA-Seq libraries 
(TPM > 1) were presented here as they were for the more stringent set in Figure 4.12.
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Supplemental Fig S4.5: Differences in N to C ratio distribution, expressed gene set. 
Differences in N to C ratio for genes with a lower TE minimum for whole cell RNA-Seq 




This figure is a summary of results shown in Figures 4.12, 4.13, and corresponding 
supplemental figures S4.4 and S4.5. For Figure 4.12 and Supplementary Figure S4.4, TE 
values were compared for sets of genes defined in the figures. Figure 4.12 used a 
“stringent” TPM cutoff for whole cell transcript abundance of > 2.  Figure S4.4 used a 
less stringent “expressed” requirement of TPM > 1.  For these gene sets, the gene set size 
yielded by each cutoff is given in the “Length of red / blue gene set” for the “expressed” 
and “stringent” gene sets.  TE difference and significance are given for the TE 
comparisons.  Additionally, N to C ratio difference and significance for sets of genes 
specified are similarly given for both gene sets.  
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